[
  {
    "title": "Broker Darlings of the Dow: Merck Ranks As a Top 15 Analyst Pick",
    "published": 1715080440,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 127.0999984741211,
      "2024-05-07T14:30:00+00:00": 128.52999877929688,
      "2024-05-07T15:30:00+00:00": 128.63499450683594,
      "2024-05-07T16:30:00+00:00": 128.75999450683594,
      "2024-05-07T17:30:00+00:00": 129.02999877929688,
      "2024-05-07T18:30:00+00:00": 129.2550048828125,
      "2024-05-07T19:30:00+00:00": 129.875
    },
    "sentiment": 0.8003191351890564
  },
  {
    "title": "CytomX Therapeutics, Merck enter CX-801 trial collaboration",
    "published": 1715056860,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 127.0999984741211,
      "2024-05-07T14:30:00+00:00": 128.52999877929688,
      "2024-05-07T15:30:00+00:00": 128.63499450683594,
      "2024-05-07T16:30:00+00:00": 128.75999450683594,
      "2024-05-07T17:30:00+00:00": 129.02999877929688,
      "2024-05-07T18:30:00+00:00": 129.2550048828125,
      "2024-05-07T19:30:00+00:00": 129.875
    },
    "sentiment": 0.7620216608047485
  },
  {
    "title": "A Look At Pharma ETFs Post Q1 Earnings",
    "published": 1715044320,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 127.0999984741211,
      "2024-05-07T14:30:00+00:00": 128.52999877929688,
      "2024-05-07T15:30:00+00:00": 128.63499450683594,
      "2024-05-07T16:30:00+00:00": 128.75999450683594,
      "2024-05-07T17:30:00+00:00": 129.02999877929688,
      "2024-05-07T18:30:00+00:00": 129.2550048828125,
      "2024-05-07T19:30:00+00:00": 129.875
    },
    "sentiment": 0.9325221180915833
  },
  {
    "title": "CG Oncology: ASCO Play And Top-Line Data End Of 2024 Could Drive Further Value",
    "published": 1715000651,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 127.18000030517578,
      "2024-05-06T14:30:00+00:00": 127.51000213623047,
      "2024-05-06T15:30:00+00:00": 127.3499984741211,
      "2024-05-06T16:30:00+00:00": 126.95989990234375,
      "2024-05-06T17:30:00+00:00": 127.16999816894531,
      "2024-05-06T18:30:00+00:00": 127.54000091552734,
      "2024-05-06T19:30:00+00:00": 127.47000122070312
    },
    "sentiment": 0.8147163391113281
  },
  {
    "title": "Summit Therapeutics' Ivonescimab: Strong Buy Its Dual-Action Approach To Cancer",
    "published": 1714993350,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 127.18000030517578,
      "2024-05-06T14:30:00+00:00": 127.51000213623047,
      "2024-05-06T15:30:00+00:00": 127.3499984741211,
      "2024-05-06T16:30:00+00:00": 126.95989990234375,
      "2024-05-06T17:30:00+00:00": 127.16999816894531,
      "2024-05-06T18:30:00+00:00": 127.54000091552734,
      "2024-05-06T19:30:00+00:00": 127.47000122070312
    },
    "sentiment": 0.927596926689148
  },
  {
    "title": "Merck First Quarter 2024 Earnings: Beats Expectations",
    "published": 1714991258,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 127.18000030517578,
      "2024-05-06T14:30:00+00:00": 127.51000213623047,
      "2024-05-06T15:30:00+00:00": 127.3499984741211,
      "2024-05-06T16:30:00+00:00": 126.95989990234375,
      "2024-05-06T17:30:00+00:00": 127.16999816894531,
      "2024-05-06T18:30:00+00:00": 127.54000091552734,
      "2024-05-06T19:30:00+00:00": 127.47000122070312
    },
    "sentiment": 0.9346625804901123
  },
  {
    "title": "Here's Why Merck (MRK) is a Strong Momentum Stock",
    "published": 1714744212,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 128.00999450683594,
      "2024-05-03T14:30:00+00:00": 127.3009033203125,
      "2024-05-03T15:30:00+00:00": 127.75,
      "2024-05-03T16:30:00+00:00": 127.83999633789062,
      "2024-05-03T17:30:00+00:00": 127.68000030517578,
      "2024-05-03T18:30:00+00:00": 127.69000244140625,
      "2024-05-03T19:30:00+00:00": 127.55999755859375
    },
    "sentiment": 0.6796325445175171
  },
  {
    "title": "MRK June 14th Options Begin Trading",
    "published": 1714734120,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 128.00999450683594,
      "2024-05-03T14:30:00+00:00": 127.3009033203125,
      "2024-05-03T15:30:00+00:00": 127.75,
      "2024-05-03T16:30:00+00:00": 127.83999633789062,
      "2024-05-03T17:30:00+00:00": 127.68000030517578,
      "2024-05-03T18:30:00+00:00": 127.69000244140625,
      "2024-05-03T19:30:00+00:00": 127.55999755859375
    },
    "sentiment": 0.9361804127693176
  },
  {
    "title": "Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration",
    "published": 1714676034,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 129.05999755859375,
      "2024-05-02T14:30:00+00:00": 129.27999877929688,
      "2024-05-02T15:30:00+00:00": 128.875,
      "2024-05-02T16:30:00+00:00": 128.77999877929688,
      "2024-05-02T17:30:00+00:00": 129.22000122070312,
      "2024-05-02T18:30:00+00:00": 129.02000427246094,
      "2024-05-02T19:30:00+00:00": 128.8000030517578
    },
    "sentiment": 0.8735291361808777
  },
  {
    "title": "Cerevance receives milestone payment under Alzheimer's collaboration with Merck",
    "published": 1714650300,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 129.05999755859375,
      "2024-05-02T14:30:00+00:00": 129.27999877929688,
      "2024-05-02T15:30:00+00:00": 128.875,
      "2024-05-02T16:30:00+00:00": 128.77999877929688,
      "2024-05-02T17:30:00+00:00": 129.22000122070312,
      "2024-05-02T18:30:00+00:00": 129.02000427246094,
      "2024-05-02T19:30:00+00:00": 128.8000030517578
    },
    "sentiment": 0.6750365495681763
  },
  {
    "title": "Janux Therapeutics gains amid renewed takeover speculation",
    "published": 1714619700,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 129.05999755859375,
      "2024-05-02T14:30:00+00:00": 129.27999877929688,
      "2024-05-02T15:30:00+00:00": 128.875,
      "2024-05-02T16:30:00+00:00": 128.77999877929688,
      "2024-05-02T17:30:00+00:00": 129.22000122070312,
      "2024-05-02T18:30:00+00:00": 129.02000427246094,
      "2024-05-02T19:30:00+00:00": 128.8000030517578
    },
    "sentiment": 0.8977920413017273
  },
  {
    "title": "3 Pharma Stocks With the Potential to Make You an Overnight Millionaire",
    "published": 1714559040,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 128.61000061035156,
      "2024-05-01T14:30:00+00:00": 129.0677947998047,
      "2024-05-01T15:30:00+00:00": 129.07000732421875,
      "2024-05-01T16:30:00+00:00": 129.05999755859375,
      "2024-05-01T17:30:00+00:00": 129.05999755859375,
      "2024-05-01T18:30:00+00:00": 129.30999755859375,
      "2024-05-01T19:30:00+00:00": 129.5500030517578
    },
    "sentiment": 0.7357757091522217
  },
  {
    "title": "Merck Keytruda combo meets main goal in late-stage trial for advanced gastric cancer",
    "published": 1714549980,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 128.61000061035156,
      "2024-05-01T14:30:00+00:00": 129.0677947998047,
      "2024-05-01T15:30:00+00:00": 129.07000732421875,
      "2024-05-01T16:30:00+00:00": 129.05999755859375,
      "2024-05-01T17:30:00+00:00": 129.05999755859375,
      "2024-05-01T18:30:00+00:00": 129.30999755859375,
      "2024-05-01T19:30:00+00:00": 129.5500030517578
    },
    "sentiment": 0.8219603896141052
  },
  {
    "title": "Merck: KEYNOTE-811 trial meets dual primary endpoint of OS",
    "published": 1714545540,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 128.61000061035156,
      "2024-05-01T14:30:00+00:00": 129.0677947998047,
      "2024-05-01T15:30:00+00:00": 129.07000732421875,
      "2024-05-01T16:30:00+00:00": 129.05999755859375,
      "2024-05-01T17:30:00+00:00": 129.05999755859375,
      "2024-05-01T18:30:00+00:00": 129.30999755859375,
      "2024-05-01T19:30:00+00:00": 129.5500030517578
    },
    "sentiment": 0.6205791234970093
  },
  {
    "title": "Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline",
    "published": 1715769900,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 128.8800048828125,
      "2024-05-15T14:30:00+00:00": 130.24000549316406,
      "2024-05-15T15:30:00+00:00": 130.39999389648438,
      "2024-05-15T16:30:00+00:00": 130.38999938964844,
      "2024-05-15T17:30:00+00:00": 131.3249969482422,
      "2024-05-15T18:30:00+00:00": 131.28030395507812,
      "2024-05-15T19:30:00+00:00": 131.2449951171875
    },
    "sentiment": 0.7574595212936401
  },
  {
    "title": "Merck to present new oncology data",
    "published": 1715767499,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 128.8800048828125,
      "2024-05-15T14:30:00+00:00": 130.24000549316406,
      "2024-05-15T15:30:00+00:00": 130.39999389648438,
      "2024-05-15T16:30:00+00:00": 130.38999938964844,
      "2024-05-15T17:30:00+00:00": 131.3249969482422,
      "2024-05-15T18:30:00+00:00": 131.28030395507812,
      "2024-05-15T19:30:00+00:00": 131.2449951171875
    },
    "sentiment": 0.9047584533691406
  },
  {
    "title": "Organon & Co Spearheads Kahn Brothers' Strategic Portfolio Enhancements in Q1 2024",
    "published": 1715738520,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 128.8800048828125,
      "2024-05-15T14:30:00+00:00": 130.24000549316406,
      "2024-05-15T15:30:00+00:00": 130.39999389648438,
      "2024-05-15T16:30:00+00:00": 130.38999938964844,
      "2024-05-15T17:30:00+00:00": 131.3249969482422,
      "2024-05-15T18:30:00+00:00": 131.28030395507812,
      "2024-05-15T19:30:00+00:00": 131.2449951171875
    },
    "sentiment": 0.7768638730049133
  },
  {
    "title": "Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility",
    "published": 1715693100,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 129.1999969482422,
      "2024-05-14T14:30:00+00:00": 128.24000549316406,
      "2024-05-14T15:30:00+00:00": 128.27000427246094,
      "2024-05-14T16:30:00+00:00": 128.2100067138672,
      "2024-05-14T17:30:00+00:00": 128.3800048828125,
      "2024-05-14T18:30:00+00:00": 128.5800018310547,
      "2024-05-14T19:30:00+00:00": 128.80499267578125
    },
    "sentiment": 0.947902500629425
  },
  {
    "title": "Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA\u00ae (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical Cancer",
    "published": 1715649367,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 129.1999969482422,
      "2024-05-14T14:30:00+00:00": 128.24000549316406,
      "2024-05-14T15:30:00+00:00": 128.27000427246094,
      "2024-05-14T16:30:00+00:00": 128.2100067138672,
      "2024-05-14T17:30:00+00:00": 128.3800048828125,
      "2024-05-14T18:30:00+00:00": 128.5800018310547,
      "2024-05-14T19:30:00+00:00": 128.80499267578125
    },
    "sentiment": 0.9109095335006714
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Merck & Co",
    "published": 1715601360,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 129.7100067138672,
      "2024-05-13T14:30:00+00:00": 128.85000610351562,
      "2024-05-13T15:30:00+00:00": 128.11000061035156,
      "2024-05-13T16:30:00+00:00": 128.25,
      "2024-05-13T17:30:00+00:00": 128.27499389648438,
      "2024-05-13T18:30:00+00:00": 128.86000061035156,
      "2024-05-13T19:30:00+00:00": 128.71499633789062
    },
    "sentiment": 0.9440696239471436
  },
  {
    "title": "Video: Dow Movers: MRK, INTC",
    "published": 1715591700,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 129.7100067138672,
      "2024-05-13T14:30:00+00:00": 128.85000610351562,
      "2024-05-13T15:30:00+00:00": 128.11000061035156,
      "2024-05-13T16:30:00+00:00": 128.25,
      "2024-05-13T17:30:00+00:00": 128.27499389648438,
      "2024-05-13T18:30:00+00:00": 128.86000061035156,
      "2024-05-13T19:30:00+00:00": 128.71499633789062
    },
    "sentiment": 0.9464547038078308
  },
  {
    "title": "Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study",
    "published": 1715587522,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 129.7100067138672,
      "2024-05-13T14:30:00+00:00": 128.85000610351562,
      "2024-05-13T15:30:00+00:00": 128.11000061035156,
      "2024-05-13T16:30:00+00:00": 128.25,
      "2024-05-13T17:30:00+00:00": 128.27499389648438,
      "2024-05-13T18:30:00+00:00": 128.86000061035156,
      "2024-05-13T19:30:00+00:00": 128.71499633789062
    },
    "sentiment": 0.8245455622673035
  },
  {
    "title": "Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years",
    "published": 1715338820,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 130.82000732421875,
      "2024-05-10T14:30:00+00:00": 130.47999572753906,
      "2024-05-10T15:30:00+00:00": 130.2899932861328,
      "2024-05-10T16:30:00+00:00": 130.4600067138672,
      "2024-05-10T17:30:00+00:00": 130.4499969482422,
      "2024-05-10T18:30:00+00:00": 130.476806640625,
      "2024-05-10T19:30:00+00:00": 130.5800018310547
    },
    "sentiment": 0.9382931590080261
  },
  {
    "title": "Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA plus Chemotherapy, With or Without Radiotherapy, for Patients with Newly Diagnosed, High-Risk Endometrial Cancer",
    "published": 1715333256,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 130.82000732421875,
      "2024-05-10T14:30:00+00:00": 130.47999572753906,
      "2024-05-10T15:30:00+00:00": 130.2899932861328,
      "2024-05-10T16:30:00+00:00": 130.4600067138672,
      "2024-05-10T17:30:00+00:00": 130.4499969482422,
      "2024-05-10T18:30:00+00:00": 130.476806640625,
      "2024-05-10T19:30:00+00:00": 130.5800018310547
    },
    "sentiment": 0.8335484862327576
  },
  {
    "title": "Health Canada Approves KEYTRUDA\u00ae for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapy",
    "published": 1715252700,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 128.94000244140625,
      "2024-05-09T14:30:00+00:00": 129.77000427246094,
      "2024-05-09T15:30:00+00:00": 129.89999389648438,
      "2024-05-09T16:30:00+00:00": 129.88999938964844,
      "2024-05-09T17:30:00+00:00": 130.13999938964844,
      "2024-05-09T18:30:00+00:00": 130.17999267578125,
      "2024-05-09T19:30:00+00:00": 130.33999633789062
    },
    "sentiment": 0.7218367457389832
  },
  {
    "title": "Merck: trial in endometrial cancer fails",
    "published": 1715243553,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 128.94000244140625,
      "2024-05-09T14:30:00+00:00": 129.77000427246094,
      "2024-05-09T15:30:00+00:00": 129.89999389648438,
      "2024-05-09T16:30:00+00:00": 129.88999938964844,
      "2024-05-09T17:30:00+00:00": 130.13999938964844,
      "2024-05-09T18:30:00+00:00": 130.17999267578125,
      "2024-05-09T19:30:00+00:00": 130.33999633789062
    },
    "sentiment": 0.8657311797142029
  },
  {
    "title": "Merck: success of 'Merck for Mothers' initiative",
    "published": 1715238925,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 128.94000244140625,
      "2024-05-09T14:30:00+00:00": 129.77000427246094,
      "2024-05-09T15:30:00+00:00": 129.89999389648438,
      "2024-05-09T16:30:00+00:00": 129.88999938964844,
      "2024-05-09T17:30:00+00:00": 130.13999938964844,
      "2024-05-09T18:30:00+00:00": 130.17999267578125,
      "2024-05-09T19:30:00+00:00": 130.33999633789062
    },
    "sentiment": 0.8383299112319946
  },
  {
    "title": "Merck provides update on Phase 3 KEYNOTE-B21 trial",
    "published": 1715233740,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 128.94000244140625,
      "2024-05-09T14:30:00+00:00": 129.77000427246094,
      "2024-05-09T15:30:00+00:00": 129.89999389648438,
      "2024-05-09T16:30:00+00:00": 129.88999938964844,
      "2024-05-09T17:30:00+00:00": 130.13999938964844,
      "2024-05-09T18:30:00+00:00": 130.17999267578125,
      "2024-05-09T19:30:00+00:00": 130.33999633789062
    },
    "sentiment": 0.9271818995475769
  },
  {
    "title": "Q1 2024 OPKO Health Inc Earnings Call",
    "published": 1715165801,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 130.5800018310547,
      "2024-05-08T14:30:00+00:00": 129.85000610351562,
      "2024-05-08T15:30:00+00:00": 129.9499969482422,
      "2024-05-08T16:30:00+00:00": 129.66000366210938,
      "2024-05-08T17:30:00+00:00": 129.5399932861328,
      "2024-05-08T18:30:00+00:00": 129.3699951171875,
      "2024-05-08T19:30:00+00:00": 129.60000610351562
    },
    "sentiment": 0.7795517444610596
  },
  {
    "title": "ASCO24: An early look at cancer drug study results",
    "published": 1716486000,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 130.89999389648438,
      "2024-05-23T14:30:00+00:00": 131.52499389648438,
      "2024-05-23T15:30:00+00:00": 131.0493927001953,
      "2024-05-23T16:30:00+00:00": 131.32000732421875,
      "2024-05-23T17:30:00+00:00": 131.1999969482422,
      "2024-05-23T18:30:00+00:00": 130.86000061035156,
      "2024-05-23T19:30:00+00:00": 131.08999633789062
    },
    "sentiment": 0.9293733835220337
  },
  {
    "title": "HPV vaccine provides real benefits for men, analysis shows",
    "published": 1716483600,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 130.89999389648438,
      "2024-05-23T14:30:00+00:00": 131.52499389648438,
      "2024-05-23T15:30:00+00:00": 131.0493927001953,
      "2024-05-23T16:30:00+00:00": 131.32000732421875,
      "2024-05-23T17:30:00+00:00": 131.1999969482422,
      "2024-05-23T18:30:00+00:00": 130.86000061035156,
      "2024-05-23T19:30:00+00:00": 131.08999633789062
    },
    "sentiment": 0.8875060081481934
  },
  {
    "title": "Merck HPV vaccine associated with lower head and neck cancer rates in men",
    "published": 1716439380,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 130.89999389648438,
      "2024-05-23T14:30:00+00:00": 131.52499389648438,
      "2024-05-23T15:30:00+00:00": 131.0493927001953,
      "2024-05-23T16:30:00+00:00": 131.32000732421875,
      "2024-05-23T17:30:00+00:00": 131.1999969482422,
      "2024-05-23T18:30:00+00:00": 130.86000061035156,
      "2024-05-23T19:30:00+00:00": 131.08999633789062
    },
    "sentiment": 0.5680679678916931
  },
  {
    "title": "Why Merck (MRK) is a Top Momentum Stock for the Long-Term",
    "published": 1716385811,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 130.1699981689453,
      "2024-05-22T14:30:00+00:00": 131.25999450683594,
      "2024-05-22T15:30:00+00:00": 130.9600067138672,
      "2024-05-22T16:30:00+00:00": 131.05999755859375,
      "2024-05-22T17:30:00+00:00": 131.25999450683594,
      "2024-05-22T18:30:00+00:00": 131.2100067138672,
      "2024-05-22T19:30:00+00:00": 131.23500061035156
    },
    "sentiment": 0.852961003780365
  },
  {
    "title": "Florida men plead guilty to fraud in scheme to export biochemicals to China",
    "published": 1716376620,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 130.1699981689453,
      "2024-05-22T14:30:00+00:00": 131.25999450683594,
      "2024-05-22T15:30:00+00:00": 130.9600067138672,
      "2024-05-22T16:30:00+00:00": 131.05999755859375,
      "2024-05-22T17:30:00+00:00": 131.25999450683594,
      "2024-05-22T18:30:00+00:00": 131.2100067138672,
      "2024-05-22T19:30:00+00:00": 131.23500061035156
    },
    "sentiment": 0.7329713106155396
  },
  {
    "title": "Wells Fargo Sticks to Their Hold Rating for Merck & Company (MRK)",
    "published": 1716351480,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 130.1699981689453,
      "2024-05-22T14:30:00+00:00": 131.25999450683594,
      "2024-05-22T15:30:00+00:00": 130.9600067138672,
      "2024-05-22T16:30:00+00:00": 131.05999755859375,
      "2024-05-22T17:30:00+00:00": 131.25999450683594,
      "2024-05-22T18:30:00+00:00": 131.2100067138672,
      "2024-05-22T19:30:00+00:00": 131.23500061035156
    },
    "sentiment": 0.8521066308021545
  },
  {
    "title": "Here's Why Merck (MRK) Stock Has Outperformed Industry YTD",
    "published": 1716210840,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 130.80999755859375,
      "2024-05-20T14:30:00+00:00": 131.49000549316406,
      "2024-05-20T15:30:00+00:00": 131.61000061035156,
      "2024-05-20T16:30:00+00:00": 131.42999267578125,
      "2024-05-20T17:30:00+00:00": 131.46499633789062,
      "2024-05-20T18:30:00+00:00": 131.5,
      "2024-05-20T19:30:00+00:00": 131.19000244140625
    },
    "sentiment": 0.5656684041023254
  },
  {
    "title": "Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness",
    "published": 1715985027,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 130.69000244140625,
      "2024-05-17T14:30:00+00:00": 130.5428924560547,
      "2024-05-17T15:30:00+00:00": 130.64999389648438,
      "2024-05-17T16:30:00+00:00": 130.6199951171875,
      "2024-05-17T17:30:00+00:00": 130.8300018310547,
      "2024-05-17T18:30:00+00:00": 130.9199981689453,
      "2024-05-17T19:30:00+00:00": 130.82000732421875
    },
    "sentiment": 0.9047989249229431
  },
  {
    "title": "Merck (MRK) Crossed Above the 20-Day Moving Average: What That Means for Investors",
    "published": 1715866503,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 131.3699951171875,
      "2024-05-16T14:30:00+00:00": 131.5,
      "2024-05-16T15:30:00+00:00": 130.85009765625,
      "2024-05-16T16:30:00+00:00": 131.00999450683594,
      "2024-05-16T17:30:00+00:00": 131.00999450683594,
      "2024-05-16T18:30:00+00:00": 131.0399932861328,
      "2024-05-16T19:30:00+00:00": 130.9499969482422
    },
    "sentiment": 0.5781812071800232
  },
  {
    "title": "Bank of America Securities Keeps Their Buy Rating on Merck & Company (MRK)",
    "published": 1715846820,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 131.3699951171875,
      "2024-05-16T14:30:00+00:00": 131.5,
      "2024-05-16T15:30:00+00:00": 130.85009765625,
      "2024-05-16T16:30:00+00:00": 131.00999450683594,
      "2024-05-16T17:30:00+00:00": 131.00999450683594,
      "2024-05-16T18:30:00+00:00": 131.0399932861328,
      "2024-05-16T19:30:00+00:00": 130.9499969482422
    },
    "sentiment": 0.9124518632888794
  },
  {
    "title": "Which Is The Best Investment For You? High Yield Pfizer Or Higher Growth Merck?",
    "published": 1715825400,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 131.3699951171875,
      "2024-05-16T14:30:00+00:00": 131.5,
      "2024-05-16T15:30:00+00:00": 130.85009765625,
      "2024-05-16T16:30:00+00:00": 131.00999450683594,
      "2024-05-16T17:30:00+00:00": 131.00999450683594,
      "2024-05-16T18:30:00+00:00": 131.0399932861328,
      "2024-05-16T19:30:00+00:00": 130.9499969482422
    },
    "sentiment": 0.9181734323501587
  },
  {
    "title": "Summit Therapeutics Stock: Plunging Despite A Win?",
    "published": 1717147650,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 125.12999725341797,
      "2024-05-31T14:30:00+00:00": 125.8499984741211,
      "2024-05-31T15:30:00+00:00": 126.16500091552734,
      "2024-05-31T16:30:00+00:00": 125.3949966430664,
      "2024-05-31T17:30:00+00:00": 125.2699966430664,
      "2024-05-31T18:30:00+00:00": 125.13999938964844,
      "2024-05-31T19:30:00+00:00": 125.12999725341797
    },
    "sentiment": 0.9124869108200073
  },
  {
    "title": "Summit pares gains as \u2018China-only\u2019 trial beats Merck\u2019s Keytruda",
    "published": 1717142460,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 125.12999725341797,
      "2024-05-31T14:30:00+00:00": 125.8499984741211,
      "2024-05-31T15:30:00+00:00": 126.16500091552734,
      "2024-05-31T16:30:00+00:00": 125.3949966430664,
      "2024-05-31T17:30:00+00:00": 125.2699966430664,
      "2024-05-31T18:30:00+00:00": 125.13999938964844,
      "2024-05-31T19:30:00+00:00": 125.12999725341797
    },
    "sentiment": 0.884441077709198
  },
  {
    "title": "Immunocore touts updated phase 1 results for melanoma asset brenetafusp",
    "published": 1717126680,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 125.12999725341797,
      "2024-05-31T14:30:00+00:00": 125.8499984741211,
      "2024-05-31T15:30:00+00:00": 126.16500091552734,
      "2024-05-31T16:30:00+00:00": 125.3949966430664,
      "2024-05-31T17:30:00+00:00": 125.2699966430664,
      "2024-05-31T18:30:00+00:00": 125.13999938964844,
      "2024-05-31T19:30:00+00:00": 125.12999725341797
    },
    "sentiment": 0.9202131628990173
  },
  {
    "title": "FDA Grants Priority Review to Merck's Application for KEYTRUDA plus Chemotherapy as First-Line Treatment of Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma",
    "published": 1717065982,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 125.9800033569336,
      "2024-05-30T14:30:00+00:00": 126.08000183105469,
      "2024-05-30T15:30:00+00:00": 126.97000122070312,
      "2024-05-30T16:30:00+00:00": 127.2699966430664,
      "2024-05-30T17:30:00+00:00": 127.79000091552734,
      "2024-05-30T18:30:00+00:00": 127.30000305175781,
      "2024-05-30T19:30:00+00:00": 124.84500122070312
    },
    "sentiment": 0.8090453147888184
  },
  {
    "title": "Summit data update not a 'significant threat' to Merck's Keytruda, says JPMorgan",
    "published": 1717044120,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 125.9800033569336,
      "2024-05-30T14:30:00+00:00": 126.08000183105469,
      "2024-05-30T15:30:00+00:00": 126.97000122070312,
      "2024-05-30T16:30:00+00:00": 127.2699966430664,
      "2024-05-30T17:30:00+00:00": 127.79000091552734,
      "2024-05-30T18:30:00+00:00": 127.30000305175781,
      "2024-05-30T19:30:00+00:00": 124.84500122070312
    },
    "sentiment": 0.7379736304283142
  },
  {
    "title": "Summit lead asset beats Merck\u2019s Keytruda in a first in lung cancer",
    "published": 1717035180,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 125.9800033569336,
      "2024-05-30T14:30:00+00:00": 126.08000183105469,
      "2024-05-30T15:30:00+00:00": 126.97000122070312,
      "2024-05-30T16:30:00+00:00": 127.2699966430664,
      "2024-05-30T17:30:00+00:00": 127.79000091552734,
      "2024-05-30T18:30:00+00:00": 127.30000305175781,
      "2024-05-30T19:30:00+00:00": 124.84500122070312
    },
    "sentiment": 0.923500657081604
  },
  {
    "title": "Merck to buy eye drug developer for $1.3B",
    "published": 1716982500,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.9162201285362244
  },
  {
    "title": "Merck\u00a0Reaches\u00a0$1.3 Billion Deal for Eye-Drug Company EyeBio",
    "published": 1716980700,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.6692619919776917
  },
  {
    "title": "AstraZeneca touts PCSK9 inhibitor in lowering LDL cholesterol when added to statin",
    "published": 1716979920,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.8726117014884949
  },
  {
    "title": "Trending : Merck to Buy Biotech Company EyeBio for $1.3 Billion",
    "published": 1716979166,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.9026152491569519
  },
  {
    "title": "Merck & Co enhances ophthalmology portfolio with EyeBio acquisition",
    "published": 1716974520,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.8972131013870239
  },
  {
    "title": "TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024",
    "published": 1716974022,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.8449106216430664
  },
  {
    "title": "Merck acquires EyeBio for $1.3 billion",
    "published": 1716970229,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.9349849224090576
  },
  {
    "title": "Merck to Acquire EyeBio for $1.3 Billion",
    "published": 1716966860,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.9315162897109985
  },
  {
    "title": "Merck to buy EyeBio in a deal that could valued at up to $3 billion",
    "published": 1716964620,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.8051244020462036
  },
  {
    "title": "Jeito Capital announces acquisition of portfolio company EyeBio by Merck",
    "published": 1716963720,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.9297534823417664
  },
  {
    "title": "Zentalis appoints Luke Walker to board of directors",
    "published": 1716963120,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.9223290085792542
  },
  {
    "title": "Merck agreed to buy EyeBio for up to $3B, FT reports",
    "published": 1716958920,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.5692936778068542
  },
  {
    "title": "M&A: Merck\u00a0(MRK) Nears Deal to Bolster Eye-care Portfolio",
    "published": 1716946260,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.9451432824134827
  },
  {
    "title": "Merck Nears $1.3 Billion Deal for Eye-Drug Company EyeBio",
    "published": 1716944640,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 126.13999938964844,
      "2024-05-29T14:30:00+00:00": 125.375,
      "2024-05-29T15:30:00+00:00": 125.8499984741211,
      "2024-05-29T16:30:00+00:00": 125.88999938964844,
      "2024-05-29T17:30:00+00:00": 125.95999908447266,
      "2024-05-29T18:30:00+00:00": 125.79499816894531,
      "2024-05-29T19:30:00+00:00": 125.91999816894531
    },
    "sentiment": 0.6869436502456665
  },
  {
    "title": "Merck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reports",
    "published": 1716931066,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.8100036978721619
  },
  {
    "title": "Merck Announces Third-Quarter 2024 Dividend",
    "published": 1716923520,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.9374309182167053
  },
  {
    "title": "Merck releases positive results from phase three Keytruda trial",
    "published": 1716909720,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.8569137454032898
  },
  {
    "title": "Merck call volume above normal and directionally bullish",
    "published": 1716896700,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.914822518825531
  },
  {
    "title": "TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment",
    "published": 1716893223,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.8643056750297546
  },
  {
    "title": "MilliporeSigma Launches First Software for Complete Data Traceability in Microbial Quality Control",
    "published": 1716890640,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.8021698594093323
  },
  {
    "title": "Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comprehensive Guide",
    "published": 1716888780,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.8350590467453003
  },
  {
    "title": "Merck: positive results for Keytruda in breast cancer",
    "published": 1716885018,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.9512168169021606
  },
  {
    "title": "GLOBAL BROKER RATINGS: Deutsche Bank raises Symrise; DZ cuts Encavis",
    "published": 1716880260,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.7016057968139648
  },
  {
    "title": "Merck says Phase 3 KEYNOTE-522 trial met its overall survival endpoint",
    "published": 1716875220,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.9500089883804321
  },
  {
    "title": "GLOBAL BRIEFING: Shanghai relaxes rules on buying property in the city",
    "published": 1716856140,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 128.83999633789062,
      "2024-05-28T14:30:00+00:00": 126.6134033203125,
      "2024-05-28T15:30:00+00:00": 126.0999984741211,
      "2024-05-28T16:30:00+00:00": 126.12999725341797,
      "2024-05-28T17:30:00+00:00": 126.13999938964844,
      "2024-05-28T18:30:00+00:00": 126.06500244140625,
      "2024-05-28T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.8582293391227722
  },
  {
    "title": "Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?",
    "published": 1716663687,
    "day_prices": {},
    "sentiment": 0.9075967073440552
  },
  {
    "title": "Merus rallies on publication of oncology study abstracts",
    "published": 1716540000,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 131.4499969482422,
      "2024-05-24T14:30:00+00:00": 130.7144012451172,
      "2024-05-24T15:30:00+00:00": 130.39999389648438,
      "2024-05-24T16:30:00+00:00": 129.6300048828125,
      "2024-05-24T17:30:00+00:00": 129.69500732421875,
      "2024-05-24T18:30:00+00:00": 129.5399932861328,
      "2024-05-24T19:30:00+00:00": 129.35499572753906
    },
    "sentiment": 0.6957874298095703
  },
  {
    "title": "How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?",
    "published": 1719688990,
    "day_prices": {},
    "sentiment": 0.781266450881958
  },
  {
    "title": "What's Going On With Merck Stock On Friday?",
    "published": 1719578372,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 129.5399932861328,
      "2024-06-28T14:30:00+00:00": 130.47000122070312,
      "2024-06-28T15:30:00+00:00": 129.27000427246094,
      "2024-06-28T16:30:00+00:00": 128.5,
      "2024-06-28T17:30:00+00:00": 128.85000610351562,
      "2024-06-28T18:30:00+00:00": 128.7949981689453,
      "2024-06-28T19:30:00+00:00": 127.80000305175781
    },
    "sentiment": 0.578950822353363
  },
  {
    "title": "Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote",
    "published": 1719574080,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 129.5399932861328,
      "2024-06-28T14:30:00+00:00": 130.47000122070312,
      "2024-06-28T15:30:00+00:00": 129.27000427246094,
      "2024-06-28T16:30:00+00:00": 128.5,
      "2024-06-28T17:30:00+00:00": 128.85000610351562,
      "2024-06-28T18:30:00+00:00": 128.7949981689453,
      "2024-06-28T19:30:00+00:00": 127.80000305175781
    },
    "sentiment": 0.6931260824203491
  },
  {
    "title": "CDC'S ACIP Unanimously Recommends Merck's CAPVAXIVE for Pneumococcal Vaccination in Appropriate Adults",
    "published": 1719569256,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 129.5399932861328,
      "2024-06-28T14:30:00+00:00": 130.47000122070312,
      "2024-06-28T15:30:00+00:00": 129.27000427246094,
      "2024-06-28T16:30:00+00:00": 128.5,
      "2024-06-28T17:30:00+00:00": 128.85000610351562,
      "2024-06-28T18:30:00+00:00": 128.7949981689453,
      "2024-06-28T19:30:00+00:00": 127.80000305175781
    },
    "sentiment": 0.685617983341217
  },
  {
    "title": "Deutsche Numis Sticks to Their Hold Rating for Merck & Company (MRK)",
    "published": 1719561960,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 129.5399932861328,
      "2024-06-28T14:30:00+00:00": 130.47000122070312,
      "2024-06-28T15:30:00+00:00": 129.27000427246094,
      "2024-06-28T16:30:00+00:00": 128.5,
      "2024-06-28T17:30:00+00:00": 128.85000610351562,
      "2024-06-28T18:30:00+00:00": 128.7949981689453,
      "2024-06-28T19:30:00+00:00": 127.80000305175781
    },
    "sentiment": 0.8688194155693054
  },
  {
    "title": "Merck Gets CHMP Backing of Winrevair in Pulmonary Arterial Hypertension",
    "published": 1719560067,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 129.5399932861328,
      "2024-06-28T14:30:00+00:00": 130.47000122070312,
      "2024-06-28T15:30:00+00:00": 129.27000427246094,
      "2024-06-28T16:30:00+00:00": 128.5,
      "2024-06-28T17:30:00+00:00": 128.85000610351562,
      "2024-06-28T18:30:00+00:00": 128.7949981689453,
      "2024-06-28T19:30:00+00:00": 127.80000305175781
    },
    "sentiment": 0.8691167235374451
  },
  {
    "title": "Merck: ACIP recommends Capvaxive for people over 65",
    "published": 1719557007,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 129.5399932861328,
      "2024-06-28T14:30:00+00:00": 130.47000122070312,
      "2024-06-28T15:30:00+00:00": 129.27000427246094,
      "2024-06-28T16:30:00+00:00": 128.5,
      "2024-06-28T17:30:00+00:00": 128.85000610351562,
      "2024-06-28T18:30:00+00:00": 128.7949981689453,
      "2024-06-28T19:30:00+00:00": 127.80000305175781
    },
    "sentiment": 0.8552043437957764
  },
  {
    "title": "Merck announces positive EU CHMP opinion for WINREVAIR",
    "published": 1719554100,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 129.5399932861328,
      "2024-06-28T14:30:00+00:00": 130.47000122070312,
      "2024-06-28T15:30:00+00:00": 129.27000427246094,
      "2024-06-28T16:30:00+00:00": 128.5,
      "2024-06-28T17:30:00+00:00": 128.85000610351562,
      "2024-06-28T18:30:00+00:00": 128.7949981689453,
      "2024-06-28T19:30:00+00:00": 127.80000305175781
    },
    "sentiment": 0.9427649974822998
  },
  {
    "title": "CDC\u2019S ACIP Unanimously Recommends Merck\u2019s CAPVAXIVE\u2122 (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults",
    "published": 1719533880,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 129.5399932861328,
      "2024-06-28T14:30:00+00:00": 130.47000122070312,
      "2024-06-28T15:30:00+00:00": 129.27000427246094,
      "2024-06-28T16:30:00+00:00": 128.5,
      "2024-06-28T17:30:00+00:00": 128.85000610351562,
      "2024-06-28T18:30:00+00:00": 128.7949981689453,
      "2024-06-28T19:30:00+00:00": 127.80000305175781
    },
    "sentiment": 0.5428370833396912
  },
  {
    "title": "IN BRIEF: Merck and Sanofi vaccine recommended for Native Americans",
    "published": 1719507480,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 131.99000549316406,
      "2024-06-27T14:30:00+00:00": 130.1300048828125,
      "2024-06-27T15:30:00+00:00": 128.99000549316406,
      "2024-06-27T16:30:00+00:00": 128.69500732421875,
      "2024-06-27T17:30:00+00:00": 128.75,
      "2024-06-27T18:30:00+00:00": 127.29000091552734,
      "2024-06-27T19:30:00+00:00": 129.4199981689453
    },
    "sentiment": 0.8566714525222778
  },
  {
    "title": "Merck : CDC\u2019s ACIP Unanimously Votes to Add Merck and Sanofi\u2019s Pediatric Hexavalent Combination Vaccine to its Preferential Recommendation to Help Prevent Invasive Hib Disease in American Indian and Alaska Native Infants - Merck.com",
    "published": 1719502873,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 131.99000549316406,
      "2024-06-27T14:30:00+00:00": 130.1300048828125,
      "2024-06-27T15:30:00+00:00": 128.99000549316406,
      "2024-06-27T16:30:00+00:00": 128.69500732421875,
      "2024-06-27T17:30:00+00:00": 128.75,
      "2024-06-27T18:30:00+00:00": 127.29000091552734,
      "2024-06-27T19:30:00+00:00": 129.4199981689453
    },
    "sentiment": 0.6705808043479919
  },
  {
    "title": "FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug",
    "published": 1719497596,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 131.99000549316406,
      "2024-06-27T14:30:00+00:00": 130.1300048828125,
      "2024-06-27T15:30:00+00:00": 128.99000549316406,
      "2024-06-27T16:30:00+00:00": 128.69500732421875,
      "2024-06-27T17:30:00+00:00": 128.75,
      "2024-06-27T18:30:00+00:00": 127.29000091552734,
      "2024-06-27T19:30:00+00:00": 129.4199981689453
    },
    "sentiment": 0.8623768091201782
  },
  {
    "title": "Merck (NYSE:MRK) Slides After \u201cGuided Missile\u201d Cancer Drug Blows Up in FDA",
    "published": 1719488100,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 131.99000549316406,
      "2024-06-27T14:30:00+00:00": 130.1300048828125,
      "2024-06-27T15:30:00+00:00": 128.99000549316406,
      "2024-06-27T16:30:00+00:00": 128.69500732421875,
      "2024-06-27T17:30:00+00:00": 128.75,
      "2024-06-27T18:30:00+00:00": 127.29000091552734,
      "2024-06-27T19:30:00+00:00": 129.4199981689453
    },
    "sentiment": 0.9506241679191589
  },
  {
    "title": "Merck, Daiichi lung cancer therapy rejected in U.S.",
    "published": 1719471720,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 131.99000549316406,
      "2024-06-27T14:30:00+00:00": 130.1300048828125,
      "2024-06-27T15:30:00+00:00": 128.99000549316406,
      "2024-06-27T16:30:00+00:00": 128.69500732421875,
      "2024-06-27T17:30:00+00:00": 128.75,
      "2024-06-27T18:30:00+00:00": 127.29000091552734,
      "2024-06-27T19:30:00+00:00": 129.4199981689453
    },
    "sentiment": 0.7946622967720032
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Nurix Therapeutics (NRIX) and Merck & Company (MRK)",
    "published": 1719467160,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 131.99000549316406,
      "2024-06-27T14:30:00+00:00": 130.1300048828125,
      "2024-06-27T15:30:00+00:00": 128.99000549316406,
      "2024-06-27T16:30:00+00:00": 128.69500732421875,
      "2024-06-27T17:30:00+00:00": 128.75,
      "2024-06-27T18:30:00+00:00": 127.29000091552734,
      "2024-06-27T19:30:00+00:00": 129.4199981689453
    },
    "sentiment": 0.9080982208251953
  },
  {
    "title": "Hold Rating on Merck Amid FDA Setback and Revenue Impact Analysis",
    "published": 1719465960,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 131.99000549316406,
      "2024-06-27T14:30:00+00:00": 130.1300048828125,
      "2024-06-27T15:30:00+00:00": 128.99000549316406,
      "2024-06-27T16:30:00+00:00": 128.69500732421875,
      "2024-06-27T17:30:00+00:00": 128.75,
      "2024-06-27T18:30:00+00:00": 127.29000091552734,
      "2024-06-27T19:30:00+00:00": 129.4199981689453
    },
    "sentiment": 0.9618094563484192
  },
  {
    "title": "A Closer Look at Merck & Co's Options Market Dynamics",
    "published": 1719456960,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 131.99000549316406,
      "2024-06-27T14:30:00+00:00": 130.1300048828125,
      "2024-06-27T15:30:00+00:00": 128.99000549316406,
      "2024-06-27T16:30:00+00:00": 128.69500732421875,
      "2024-06-27T17:30:00+00:00": 128.75,
      "2024-06-27T18:30:00+00:00": 127.29000091552734,
      "2024-06-27T19:30:00+00:00": 129.4199981689453
    },
    "sentiment": 0.9133328795433044
  },
  {
    "title": "Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst",
    "published": 1719413337,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 133.3800048828125,
      "2024-06-26T14:30:00+00:00": 132.64999389648438,
      "2024-06-26T15:30:00+00:00": 133.25999450683594,
      "2024-06-26T16:30:00+00:00": 133.27499389648438,
      "2024-06-26T17:30:00+00:00": 132.5399932861328,
      "2024-06-26T18:30:00+00:00": 132.2899932861328,
      "2024-06-26T19:30:00+00:00": 132.1699981689453
    },
    "sentiment": 0.6353901624679565
  },
  {
    "title": "Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight",
    "published": 1719398040,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 133.3800048828125,
      "2024-06-26T14:30:00+00:00": 132.64999389648438,
      "2024-06-26T15:30:00+00:00": 133.25999450683594,
      "2024-06-26T16:30:00+00:00": 133.27499389648438,
      "2024-06-26T17:30:00+00:00": 132.5399932861328,
      "2024-06-26T18:30:00+00:00": 132.2899932861328,
      "2024-06-26T19:30:00+00:00": 132.1699981689453
    },
    "sentiment": 0.6092404723167419
  },
  {
    "title": "Kepler Capital  Sticks to Their Buy Rating for Merck KGaA (0O14)",
    "published": 1719391560,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 133.3800048828125,
      "2024-06-26T14:30:00+00:00": 132.64999389648438,
      "2024-06-26T15:30:00+00:00": 133.25999450683594,
      "2024-06-26T16:30:00+00:00": 133.27499389648438,
      "2024-06-26T17:30:00+00:00": 132.5399932861328,
      "2024-06-26T18:30:00+00:00": 132.2899932861328,
      "2024-06-26T19:30:00+00:00": 132.1699981689453
    },
    "sentiment": 0.763905942440033
  },
  {
    "title": "Pharma M&A: The top high value deals in 2023",
    "published": 1719385933,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 133.3800048828125,
      "2024-06-26T14:30:00+00:00": 132.64999389648438,
      "2024-06-26T15:30:00+00:00": 133.25999450683594,
      "2024-06-26T16:30:00+00:00": 133.27499389648438,
      "2024-06-26T17:30:00+00:00": 132.5399932861328,
      "2024-06-26T18:30:00+00:00": 132.2899932861328,
      "2024-06-26T19:30:00+00:00": 132.1699981689453
    },
    "sentiment": 0.5183050036430359
  },
  {
    "title": "Merck: US approval for canine flu vaccine",
    "published": 1719375857,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 133.3800048828125,
      "2024-06-26T14:30:00+00:00": 132.64999389648438,
      "2024-06-26T15:30:00+00:00": 133.25999450683594,
      "2024-06-26T16:30:00+00:00": 133.27499389648438,
      "2024-06-26T17:30:00+00:00": 132.5399932861328,
      "2024-06-26T18:30:00+00:00": 132.2899932861328,
      "2024-06-26T19:30:00+00:00": 132.1699981689453
    },
    "sentiment": 0.8550466895103455
  },
  {
    "title": "Buy Rating on Merck & Co. Anchored by Capvaxive\u2019s Market Capture and Cost-Effectiveness Prospects",
    "published": 1719369480,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 133.3800048828125,
      "2024-06-26T14:30:00+00:00": 132.64999389648438,
      "2024-06-26T15:30:00+00:00": 133.25999450683594,
      "2024-06-26T16:30:00+00:00": 133.27499389648438,
      "2024-06-26T17:30:00+00:00": 132.5399932861328,
      "2024-06-26T18:30:00+00:00": 132.2899932861328,
      "2024-06-26T19:30:00+00:00": 132.1699981689453
    },
    "sentiment": 0.9187109470367432
  },
  {
    "title": "USDA Approves Merck Animal Health\u2019s NOBIVAC\u00ae NXT Canine Flu H3N2 \u2013 The First and Only RNA-Particle Technology Vaccine for Canine Influenza",
    "published": 1719345900,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 133.08999633789062,
      "2024-06-25T14:30:00+00:00": 134.25,
      "2024-06-25T15:30:00+00:00": 133.3300018310547,
      "2024-06-25T16:30:00+00:00": 132.8000030517578,
      "2024-06-25T17:30:00+00:00": 133.10000610351562,
      "2024-06-25T18:30:00+00:00": 133.25999450683594,
      "2024-06-25T19:30:00+00:00": 133.05999755859375
    },
    "sentiment": 0.8071524500846863
  },
  {
    "title": "Merck Animal Division's Dog Flu Treatment Gets Agriculture Department Approval",
    "published": 1719333440,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 133.08999633789062,
      "2024-06-25T14:30:00+00:00": 134.25,
      "2024-06-25T15:30:00+00:00": 133.3300018310547,
      "2024-06-25T16:30:00+00:00": 132.8000030517578,
      "2024-06-25T17:30:00+00:00": 133.10000610351562,
      "2024-06-25T18:30:00+00:00": 133.25999450683594,
      "2024-06-25T19:30:00+00:00": 133.05999755859375
    },
    "sentiment": 0.49935030937194824
  },
  {
    "title": "Merck shares fall as phase three xevinapant trials discontinued",
    "published": 1719288780,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 133.08999633789062,
      "2024-06-25T14:30:00+00:00": 134.25,
      "2024-06-25T15:30:00+00:00": 133.3300018310547,
      "2024-06-25T16:30:00+00:00": 132.8000030517578,
      "2024-06-25T17:30:00+00:00": 133.10000610351562,
      "2024-06-25T18:30:00+00:00": 133.25999450683594,
      "2024-06-25T19:30:00+00:00": 133.05999755859375
    },
    "sentiment": 0.9609549045562744
  },
  {
    "title": "Buy Rating Affirmed for Merck KGaA Despite Xevinapant Setback",
    "published": 1719287820,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 133.08999633789062,
      "2024-06-25T14:30:00+00:00": 134.25,
      "2024-06-25T15:30:00+00:00": 133.3300018310547,
      "2024-06-25T16:30:00+00:00": 132.8000030517578,
      "2024-06-25T17:30:00+00:00": 133.10000610351562,
      "2024-06-25T18:30:00+00:00": 133.25999450683594,
      "2024-06-25T19:30:00+00:00": 133.05999755859375
    },
    "sentiment": 0.9463460445404053
  },
  {
    "title": "USDA approves Merck Animal Health's NOBIVAC",
    "published": 1719284820,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 133.08999633789062,
      "2024-06-25T14:30:00+00:00": 134.25,
      "2024-06-25T15:30:00+00:00": 133.3300018310547,
      "2024-06-25T16:30:00+00:00": 132.8000030517578,
      "2024-06-25T17:30:00+00:00": 133.10000610351562,
      "2024-06-25T18:30:00+00:00": 133.25999450683594,
      "2024-06-25T19:30:00+00:00": 133.05999755859375
    },
    "sentiment": 0.7424687743186951
  },
  {
    "title": "Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth",
    "published": 1719280020,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 133.08999633789062,
      "2024-06-25T14:30:00+00:00": 134.25,
      "2024-06-25T15:30:00+00:00": 133.3300018310547,
      "2024-06-25T16:30:00+00:00": 132.8000030517578,
      "2024-06-25T17:30:00+00:00": 133.10000610351562,
      "2024-06-25T18:30:00+00:00": 133.25999450683594,
      "2024-06-25T19:30:00+00:00": 133.05999755859375
    },
    "sentiment": 0.5376772284507751
  },
  {
    "title": "Merck (MRK) Increases Despite Market Slip: Here's What You Need to Know",
    "published": 1719265818,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 131.27000427246094,
      "2024-06-24T14:30:00+00:00": 131.86000061035156,
      "2024-06-24T15:30:00+00:00": 132.1999969482422,
      "2024-06-24T16:30:00+00:00": 132.24000549316406,
      "2024-06-24T17:30:00+00:00": 132.35000610351562,
      "2024-06-24T18:30:00+00:00": 132.50999450683594,
      "2024-06-24T19:30:00+00:00": 132.36000061035156
    },
    "sentiment": 0.8669723868370056
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) a Strong Buy Right Now?",
    "published": 1719238662,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 131.27000427246094,
      "2024-06-24T14:30:00+00:00": 131.86000061035156,
      "2024-06-24T15:30:00+00:00": 132.1999969482422,
      "2024-06-24T16:30:00+00:00": 132.24000549316406,
      "2024-06-24T17:30:00+00:00": 132.35000610351562,
      "2024-06-24T18:30:00+00:00": 132.50999450683594,
      "2024-06-24T19:30:00+00:00": 132.36000061035156
    },
    "sentiment": 0.7610445022583008
  },
  {
    "title": "5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More",
    "published": 1719201480,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 131.27000427246094,
      "2024-06-24T14:30:00+00:00": 131.86000061035156,
      "2024-06-24T15:30:00+00:00": 132.1999969482422,
      "2024-06-24T16:30:00+00:00": 132.24000549316406,
      "2024-06-24T17:30:00+00:00": 132.35000610351562,
      "2024-06-24T18:30:00+00:00": 132.50999450683594,
      "2024-06-24T19:30:00+00:00": 132.36000061035156
    },
    "sentiment": 0.7755900025367737
  },
  {
    "title": "With 78% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners",
    "published": 1719057616,
    "day_prices": {},
    "sentiment": 0.9439083337783813
  },
  {
    "title": "3 Top Penny Stocks to Skyrocket Your Wealth in 2024",
    "published": 1718948520,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 130.1699981689453,
      "2024-06-21T14:30:00+00:00": 130.4600067138672,
      "2024-06-21T15:30:00+00:00": 129.1199951171875,
      "2024-06-21T16:30:00+00:00": 129.41000366210938,
      "2024-06-21T17:30:00+00:00": 129.61000061035156,
      "2024-06-21T18:30:00+00:00": 130.07000732421875,
      "2024-06-21T19:30:00+00:00": 129.89039611816406
    },
    "sentiment": 0.7693461179733276
  },
  {
    "title": "Esperion downgraded to Underperform from Neutral at BofA",
    "published": 1718860020,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 127.38999938964844,
      "2024-06-20T14:30:00+00:00": 128.34649658203125,
      "2024-06-20T15:30:00+00:00": 129.0800018310547,
      "2024-06-20T16:30:00+00:00": 129.1300048828125,
      "2024-06-20T17:30:00+00:00": 129.57000732421875,
      "2024-06-20T18:30:00+00:00": 130.35000610351562,
      "2024-06-20T19:30:00+00:00": 129.92999267578125
    },
    "sentiment": 0.8350778818130493
  },
  {
    "title": "MSD competes with Pfizer in pneumococcal vaccine market after FDA approval",
    "published": 1718730153,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.8515430092811584
  },
  {
    "title": "FDA approves Merck's pneumonia vaccine for adults",
    "published": 1718724375,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.5974026918411255
  },
  {
    "title": "Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval",
    "published": 1718715240,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.9259472489356995
  },
  {
    "title": "Merck: new FDA approval for Keytruda",
    "published": 1718706437,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.7869659066200256
  },
  {
    "title": "FDA Approves Merck s KEYTRUDA plus Carboplatin and Paclitaxel as Treatment for Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma",
    "published": 1718704009,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.8927720785140991
  },
  {
    "title": "MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson\u2019s Research",
    "published": 1718697600,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.8328361511230469
  },
  {
    "title": "FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults",
    "published": 1718694660,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.7023932337760925
  },
  {
    "title": "FDA Approves Merck\u2019s (MRK) New Vaccine, Capvaxive",
    "published": 1718691120,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.833742618560791
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Globus Medical (GMED) and Merck & Company (MRK)",
    "published": 1718687460,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.908467710018158
  },
  {
    "title": "Merck treatment of gastric cancer granted FDA orphan designation",
    "published": 1718675940,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 128.27000427246094,
      "2024-06-18T14:30:00+00:00": 127.38040161132812,
      "2024-06-18T15:30:00+00:00": 127.79000091552734,
      "2024-06-18T16:30:00+00:00": 127.83000183105469,
      "2024-06-18T17:30:00+00:00": 128.19000244140625,
      "2024-06-18T18:30:00+00:00": 128.32000732421875,
      "2024-06-18T19:30:00+00:00": 127.86000061035156
    },
    "sentiment": 0.554214596748352
  },
  {
    "title": "U.S. FDA Approves CAPVAXIVE\u2122 (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults",
    "published": 1718659740,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 128.2100067138672,
      "2024-06-17T14:30:00+00:00": 128.4499969482422,
      "2024-06-17T15:30:00+00:00": 128.27000427246094,
      "2024-06-17T16:30:00+00:00": 127.68000030517578,
      "2024-06-17T17:30:00+00:00": 127.61579895019531,
      "2024-06-17T18:30:00+00:00": 127.5999984741211,
      "2024-06-17T19:30:00+00:00": 127.5199966430664
    },
    "sentiment": 0.8872432112693787
  },
  {
    "title": "Merck Get FDA Approval for Keytruda to Treat Endometerial Cancer",
    "published": 1718647033,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 128.2100067138672,
      "2024-06-17T14:30:00+00:00": 128.4499969482422,
      "2024-06-17T15:30:00+00:00": 128.27000427246094,
      "2024-06-17T16:30:00+00:00": 127.68000030517578,
      "2024-06-17T17:30:00+00:00": 127.61579895019531,
      "2024-06-17T18:30:00+00:00": 127.5999984741211,
      "2024-06-17T19:30:00+00:00": 127.5199966430664
    },
    "sentiment": 0.8888994455337524
  },
  {
    "title": "FDA approves pembro plus chemo for endometrial carcinoma",
    "published": 1718624040,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 128.2100067138672,
      "2024-06-17T14:30:00+00:00": 128.4499969482422,
      "2024-06-17T15:30:00+00:00": 128.27000427246094,
      "2024-06-17T16:30:00+00:00": 127.68000030517578,
      "2024-06-17T17:30:00+00:00": 127.61579895019531,
      "2024-06-17T18:30:00+00:00": 127.5999984741211,
      "2024-06-17T19:30:00+00:00": 127.5199966430664
    },
    "sentiment": 0.5610092878341675
  },
  {
    "title": "Merck gets FDA approval for Capvaxive pneumonia vaccine (update)",
    "published": 1718600880,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 128.2100067138672,
      "2024-06-17T14:30:00+00:00": 128.4499969482422,
      "2024-06-17T15:30:00+00:00": 128.27000427246094,
      "2024-06-17T16:30:00+00:00": 127.68000030517578,
      "2024-06-17T17:30:00+00:00": 127.61579895019531,
      "2024-06-17T18:30:00+00:00": 127.5999984741211,
      "2024-06-17T19:30:00+00:00": 127.5199966430664
    },
    "sentiment": 0.6715285181999207
  },
  {
    "title": "FDA approves Merck's CAPVAXIVE in IPD cases",
    "published": 1718598780,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 128.2100067138672,
      "2024-06-17T14:30:00+00:00": 128.4499969482422,
      "2024-06-17T15:30:00+00:00": 128.27000427246094,
      "2024-06-17T16:30:00+00:00": 127.68000030517578,
      "2024-06-17T17:30:00+00:00": 127.61579895019531,
      "2024-06-17T18:30:00+00:00": 127.5999984741211,
      "2024-06-17T19:30:00+00:00": 127.5199966430664
    },
    "sentiment": 0.6628845930099487
  },
  {
    "title": "Is Merck & Co. Inc. (NYSE:MRK) The Best Healthcare Stock to Buy in 2024?",
    "published": 1718278734,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 130.02000427246094,
      "2024-06-13T14:30:00+00:00": 129.36590576171875,
      "2024-06-13T15:30:00+00:00": 129.1300048828125,
      "2024-06-13T16:30:00+00:00": 128.63999938964844,
      "2024-06-13T17:30:00+00:00": 129.25,
      "2024-06-13T18:30:00+00:00": 129.36000061035156,
      "2024-06-13T19:30:00+00:00": 129.25
    },
    "sentiment": 0.8777121901512146
  },
  {
    "title": "Women in Science? At Merck, Absolutely",
    "published": 1718210700,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 132.6999969482422,
      "2024-06-12T14:30:00+00:00": 131.22000122070312,
      "2024-06-12T15:30:00+00:00": 130.85000610351562,
      "2024-06-12T16:30:00+00:00": 130.77999877929688,
      "2024-06-12T17:30:00+00:00": 130.99000549316406,
      "2024-06-12T18:30:00+00:00": 130.5399932861328,
      "2024-06-12T19:30:00+00:00": 130.5399932861328
    },
    "sentiment": 0.9359928965568542
  },
  {
    "title": "Neutral Hold Rating for Merck\u2019s Winrevair Amid Modest Sales Impact and Market Penetration Concerns",
    "published": 1718170680,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 132.6999969482422,
      "2024-06-12T14:30:00+00:00": 131.22000122070312,
      "2024-06-12T15:30:00+00:00": 130.85000610351562,
      "2024-06-12T16:30:00+00:00": 130.77999877929688,
      "2024-06-12T17:30:00+00:00": 130.99000549316406,
      "2024-06-12T18:30:00+00:00": 130.5399932861328,
      "2024-06-12T19:30:00+00:00": 130.5399932861328
    },
    "sentiment": 0.6804257035255432
  },
  {
    "title": "Daiichi Sankyo Is Riding The ADC Revolution To Billions In Future Revenue",
    "published": 1718162878,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 132.6999969482422,
      "2024-06-12T14:30:00+00:00": 131.22000122070312,
      "2024-06-12T15:30:00+00:00": 130.85000610351562,
      "2024-06-12T16:30:00+00:00": 130.77999877929688,
      "2024-06-12T17:30:00+00:00": 130.99000549316406,
      "2024-06-12T18:30:00+00:00": 130.5399932861328,
      "2024-06-12T19:30:00+00:00": 130.5399932861328
    },
    "sentiment": 0.7453760504722595
  },
  {
    "title": "Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data",
    "published": 1718121225,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 131.0,
      "2024-06-11T14:30:00+00:00": 130.64999389648438,
      "2024-06-11T15:30:00+00:00": 130.8000030517578,
      "2024-06-11T16:30:00+00:00": 131.19000244140625,
      "2024-06-11T17:30:00+00:00": 131.1999969482422,
      "2024-06-11T18:30:00+00:00": 131.6699981689453,
      "2024-06-11T19:30:00+00:00": 131.91000366210938
    },
    "sentiment": 0.9566398859024048
  },
  {
    "title": "Aerovate: Imatinib Delivery Change Leads To Targeting Of Massive PAH Market",
    "published": 1718111953,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 131.0,
      "2024-06-11T14:30:00+00:00": 130.64999389648438,
      "2024-06-11T15:30:00+00:00": 130.8000030517578,
      "2024-06-11T16:30:00+00:00": 131.19000244140625,
      "2024-06-11T17:30:00+00:00": 131.1999969482422,
      "2024-06-11T18:30:00+00:00": 131.6699981689453,
      "2024-06-11T19:30:00+00:00": 131.91000366210938
    },
    "sentiment": 0.34575551748275757
  },
  {
    "title": "Corcept Therapeutics Stock Merits Accumulation",
    "published": 1718107725,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 131.0,
      "2024-06-11T14:30:00+00:00": 130.64999389648438,
      "2024-06-11T15:30:00+00:00": 130.8000030517578,
      "2024-06-11T16:30:00+00:00": 131.19000244140625,
      "2024-06-11T17:30:00+00:00": 131.1999969482422,
      "2024-06-11T18:30:00+00:00": 131.6699981689453,
      "2024-06-11T19:30:00+00:00": 131.91000366210938
    },
    "sentiment": 0.7738778591156006
  },
  {
    "title": "3 High-Yield Dividend Stocks to Collect Impressive Payouts Year After Year",
    "published": 1718103600,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 131.0,
      "2024-06-11T14:30:00+00:00": 130.64999389648438,
      "2024-06-11T15:30:00+00:00": 130.8000030517578,
      "2024-06-11T16:30:00+00:00": 131.19000244140625,
      "2024-06-11T17:30:00+00:00": 131.1999969482422,
      "2024-06-11T18:30:00+00:00": 131.6699981689453,
      "2024-06-11T19:30:00+00:00": 131.91000366210938
    },
    "sentiment": 0.9006057977676392
  },
  {
    "title": "Affimed: AFM24's Update Was Good, Acimtamig's Should Be Better",
    "published": 1718095052,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 131.0,
      "2024-06-11T14:30:00+00:00": 130.64999389648438,
      "2024-06-11T15:30:00+00:00": 130.8000030517578,
      "2024-06-11T16:30:00+00:00": 131.19000244140625,
      "2024-06-11T17:30:00+00:00": 131.1999969482422,
      "2024-06-11T18:30:00+00:00": 131.6699981689453,
      "2024-06-11T19:30:00+00:00": 131.91000366210938
    },
    "sentiment": 0.9338229298591614
  },
  {
    "title": "Dividends And Innovation: Why Merck Is A Healthcare Stock Worth Buying",
    "published": 1718015033,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 130.6300048828125,
      "2024-06-10T14:30:00+00:00": 129.83999633789062,
      "2024-06-10T15:30:00+00:00": 129.89999389648438,
      "2024-06-10T16:30:00+00:00": 130.11500549316406,
      "2024-06-10T17:30:00+00:00": 130.6300048828125,
      "2024-06-10T18:30:00+00:00": 131.08999633789062,
      "2024-06-10T19:30:00+00:00": 131.49000549316406
    },
    "sentiment": 0.8829364776611328
  },
  {
    "title": "Nike, Merck, General Motors, And More: CNBC's 'Final Trades'",
    "published": 1718003820,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 130.6300048828125,
      "2024-06-10T14:30:00+00:00": 129.83999633789062,
      "2024-06-10T15:30:00+00:00": 129.89999389648438,
      "2024-06-10T16:30:00+00:00": 130.11500549316406,
      "2024-06-10T17:30:00+00:00": 130.6300048828125,
      "2024-06-10T18:30:00+00:00": 131.08999633789062,
      "2024-06-10T19:30:00+00:00": 131.49000549316406
    },
    "sentiment": 0.9438849091529846
  },
  {
    "title": "Investors more bullish on Merck (NYSE:MRK) this week as stock climbs 4.1%, despite earnings trending downwards over past three years",
    "published": 1717934472,
    "day_prices": {},
    "sentiment": 0.5981752276420593
  },
  {
    "title": "Geron jumps as FDA approves lead asset for blood cancer",
    "published": 1717738860,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 130.35000610351562,
      "2024-06-07T14:30:00+00:00": 131.10499572753906,
      "2024-06-07T15:30:00+00:00": 130.9499969482422,
      "2024-06-07T16:30:00+00:00": 130.67999267578125,
      "2024-06-07T17:30:00+00:00": 130.6199951171875,
      "2024-06-07T18:30:00+00:00": 130.66000366210938,
      "2024-06-07T19:30:00+00:00": 130.68499755859375
    },
    "sentiment": 0.5721284747123718
  },
  {
    "title": "ASCO 2024 Round-Up: Some Of The Most Impactful Cancer News Out Of The Big Meeting",
    "published": 1717664830,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 129.16000366210938,
      "2024-06-06T14:30:00+00:00": 130.6699981689453,
      "2024-06-06T15:30:00+00:00": 130.7100067138672,
      "2024-06-06T16:30:00+00:00": 129.97999572753906,
      "2024-06-06T17:30:00+00:00": 129.6199951171875,
      "2024-06-06T18:30:00+00:00": 129.7899932861328,
      "2024-06-06T19:30:00+00:00": 130.4499969482422
    },
    "sentiment": 0.8828467726707458
  },
  {
    "title": "MOBILion Shows Off MOBIE System at ASMS 2024",
    "published": 1717620416,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 128.47999572753906,
      "2024-06-05T14:30:00+00:00": 128.3000030517578,
      "2024-06-05T15:30:00+00:00": 129.58999633789062,
      "2024-06-05T16:30:00+00:00": 129.41000366210938,
      "2024-06-05T17:30:00+00:00": 129.6999969482422,
      "2024-06-05T18:30:00+00:00": 129.85000610351562,
      "2024-06-05T19:30:00+00:00": 129.8000030517578
    },
    "sentiment": 0.9127147793769836
  },
  {
    "title": "Coherus Biosciences appoints Karachun to board of directors",
    "published": 1717575180,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 128.47999572753906,
      "2024-06-05T14:30:00+00:00": 128.3000030517578,
      "2024-06-05T15:30:00+00:00": 129.58999633789062,
      "2024-06-05T16:30:00+00:00": 129.41000366210938,
      "2024-06-05T17:30:00+00:00": 129.6999969482422,
      "2024-06-05T18:30:00+00:00": 129.85000610351562,
      "2024-06-05T19:30:00+00:00": 129.8000030517578
    },
    "sentiment": 0.9278608560562134
  },
  {
    "title": "Merck a Top 25 Dividend Giant With 2.39% Yield (MRK)",
    "published": 1717568880,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 128.47999572753906,
      "2024-06-05T14:30:00+00:00": 128.3000030517578,
      "2024-06-05T15:30:00+00:00": 129.58999633789062,
      "2024-06-05T16:30:00+00:00": 129.41000366210938,
      "2024-06-05T17:30:00+00:00": 129.6999969482422,
      "2024-06-05T18:30:00+00:00": 129.85000610351562,
      "2024-06-05T19:30:00+00:00": 129.8000030517578
    },
    "sentiment": 0.8461142778396606
  },
  {
    "title": "Merck & Co., Inc. (MRK) Investor Event at ASCO 2024 (Transcript)",
    "published": 1717507863,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 127.1500015258789,
      "2024-06-04T14:30:00+00:00": 129.0399932861328,
      "2024-06-04T15:30:00+00:00": 129.0800018310547,
      "2024-06-04T16:30:00+00:00": 128.88009643554688,
      "2024-06-04T17:30:00+00:00": 128.38999938964844,
      "2024-06-04T18:30:00+00:00": 129.0,
      "2024-06-04T19:30:00+00:00": 128.8800048828125
    },
    "sentiment": 0.937865138053894
  },
  {
    "title": "Marks Electrical Group Announces Upcoming Results",
    "published": 1717500840,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 127.1500015258789,
      "2024-06-04T14:30:00+00:00": 129.0399932861328,
      "2024-06-04T15:30:00+00:00": 129.0800018310547,
      "2024-06-04T16:30:00+00:00": 128.88009643554688,
      "2024-06-04T17:30:00+00:00": 128.38999938964844,
      "2024-06-04T18:30:00+00:00": 129.0,
      "2024-06-04T19:30:00+00:00": 128.8800048828125
    },
    "sentiment": 0.8498609066009521
  },
  {
    "title": "Buy Rating Affirmed on Merck\u2019s Promising Oncology Pipeline and Keytruda\u2019s Commercial Success",
    "published": 1717490160,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 127.1500015258789,
      "2024-06-04T14:30:00+00:00": 129.0399932861328,
      "2024-06-04T15:30:00+00:00": 129.0800018310547,
      "2024-06-04T16:30:00+00:00": 128.88009643554688,
      "2024-06-04T17:30:00+00:00": 128.38999938964844,
      "2024-06-04T18:30:00+00:00": 129.0,
      "2024-06-04T19:30:00+00:00": 128.8800048828125
    },
    "sentiment": 0.9338698387145996
  },
  {
    "title": "Merus price target raised by $7 at BMO Capital, here's why",
    "published": 1717488360,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 127.1500015258789,
      "2024-06-04T14:30:00+00:00": 129.0399932861328,
      "2024-06-04T15:30:00+00:00": 129.0800018310547,
      "2024-06-04T16:30:00+00:00": 128.88009643554688,
      "2024-06-04T17:30:00+00:00": 128.38999938964844,
      "2024-06-04T18:30:00+00:00": 129.0,
      "2024-06-04T19:30:00+00:00": 128.8800048828125
    },
    "sentiment": 0.7223950028419495
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Merck & Company (MRK)",
    "published": 1717484460,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 127.1500015258789,
      "2024-06-04T14:30:00+00:00": 129.0399932861328,
      "2024-06-04T15:30:00+00:00": 129.0800018310547,
      "2024-06-04T16:30:00+00:00": 128.88009643554688,
      "2024-06-04T17:30:00+00:00": 128.38999938964844,
      "2024-06-04T18:30:00+00:00": 129.0,
      "2024-06-04T19:30:00+00:00": 128.8800048828125
    },
    "sentiment": 0.9164083003997803
  },
  {
    "title": "Buy Rating Affirmed: Merck\u2019s Oncology Advances and Strategic Positioning Promote Growth",
    "published": 1717481220,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 127.1500015258789,
      "2024-06-04T14:30:00+00:00": 129.0399932861328,
      "2024-06-04T15:30:00+00:00": 129.0800018310547,
      "2024-06-04T16:30:00+00:00": 128.88009643554688,
      "2024-06-04T17:30:00+00:00": 128.38999938964844,
      "2024-06-04T18:30:00+00:00": 129.0,
      "2024-06-04T19:30:00+00:00": 128.8800048828125
    },
    "sentiment": 0.9388238787651062
  },
  {
    "title": "Maintaining Hold: Merck & Co.\u2019s Promising Trials and Strategic Partnerships Reflect Current Valuation",
    "published": 1717475820,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 127.1500015258789,
      "2024-06-04T14:30:00+00:00": 129.0399932861328,
      "2024-06-04T15:30:00+00:00": 129.0800018310547,
      "2024-06-04T16:30:00+00:00": 128.88009643554688,
      "2024-06-04T17:30:00+00:00": 128.38999938964844,
      "2024-06-04T18:30:00+00:00": 129.0,
      "2024-06-04T19:30:00+00:00": 128.8800048828125
    },
    "sentiment": 0.860177218914032
  },
  {
    "title": "Moderna and Merck's Keytruda reduces death, recurrence of melanoma",
    "published": 1717433520,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 125.7699966430664,
      "2024-06-03T14:30:00+00:00": 128.61000061035156,
      "2024-06-03T15:30:00+00:00": 128.91000366210938,
      "2024-06-03T16:30:00+00:00": 127.79000091552734,
      "2024-06-03T17:30:00+00:00": 128.07000732421875,
      "2024-06-03T18:30:00+00:00": 127.93000030517578,
      "2024-06-03T19:30:00+00:00": 128.22000122070312
    },
    "sentiment": 0.8672833442687988
  },
  {
    "title": "Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection",
    "published": 1717416000,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 125.7699966430664,
      "2024-06-03T14:30:00+00:00": 128.61000061035156,
      "2024-06-03T15:30:00+00:00": 128.91000366210938,
      "2024-06-03T16:30:00+00:00": 127.79000091552734,
      "2024-06-03T17:30:00+00:00": 128.07000732421875,
      "2024-06-03T18:30:00+00:00": 127.93000030517578,
      "2024-06-03T19:30:00+00:00": 128.22000122070312
    },
    "sentiment": 0.9544124603271484
  },
  {
    "title": "Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial",
    "published": 1717408602,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 125.7699966430664,
      "2024-06-03T14:30:00+00:00": 128.61000061035156,
      "2024-06-03T15:30:00+00:00": 128.91000366210938,
      "2024-06-03T16:30:00+00:00": 127.79000091552734,
      "2024-06-03T17:30:00+00:00": 128.07000732421875,
      "2024-06-03T18:30:00+00:00": 127.93000030517578,
      "2024-06-03T19:30:00+00:00": 128.22000122070312
    },
    "sentiment": 0.9451234936714172
  },
  {
    "title": "Merck KGaA, Darmstadt, Germany\u2019s Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment",
    "published": 1717405200,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 125.7699966430664,
      "2024-06-03T14:30:00+00:00": 128.61000061035156,
      "2024-06-03T15:30:00+00:00": 128.91000366210938,
      "2024-06-03T16:30:00+00:00": 127.79000091552734,
      "2024-06-03T17:30:00+00:00": 128.07000732421875,
      "2024-06-03T18:30:00+00:00": 127.93000030517578,
      "2024-06-03T19:30:00+00:00": 128.22000122070312
    },
    "sentiment": 0.8205760717391968
  },
  {
    "title": "Moderna, Merck announce 3-year data for mRNA-4157 in combination with Keytruda",
    "published": 1717400220,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 125.7699966430664,
      "2024-06-03T14:30:00+00:00": 128.61000061035156,
      "2024-06-03T15:30:00+00:00": 128.91000366210938,
      "2024-06-03T16:30:00+00:00": 127.79000091552734,
      "2024-06-03T17:30:00+00:00": 128.07000732421875,
      "2024-06-03T18:30:00+00:00": 127.93000030517578,
      "2024-06-03T19:30:00+00:00": 128.22000122070312
    },
    "sentiment": 0.8182031512260437
  },
  {
    "title": "Large Cap BIopharmaceuticals Overview",
    "published": 1717389900,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 125.7699966430664,
      "2024-06-03T14:30:00+00:00": 128.61000061035156,
      "2024-06-03T15:30:00+00:00": 128.91000366210938,
      "2024-06-03T16:30:00+00:00": 127.79000091552734,
      "2024-06-03T17:30:00+00:00": 128.07000732421875,
      "2024-06-03T18:30:00+00:00": 127.93000030517578,
      "2024-06-03T19:30:00+00:00": 128.22000122070312
    },
    "sentiment": 0.9202703833580017
  },
  {
    "title": "Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership",
    "published": 1717297200,
    "day_prices": {},
    "sentiment": 0.917879581451416
  },
  {
    "title": "Emerging and Chinese pharmas playing greater role in oncology drug development",
    "published": 1717290120,
    "day_prices": {},
    "sentiment": 0.5788831114768982
  },
  {
    "title": "Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly",
    "published": 1717243219,
    "day_prices": {},
    "sentiment": 0.539949357509613
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Glaukos (GKOS) and Arcus Biosciences (RCUS)",
    "published": 1717233660,
    "day_prices": {},
    "sentiment": 0.9174324870109558
  },
  {
    "title": "Ocular Therapeutix: Unveiling Pipeline Progress (AXPAXLI, PAXTRAVA) And Q1 Results",
    "published": 1717219837,
    "day_prices": {},
    "sentiment": 0.8091071844100952
  },
  {
    "title": "Revenue growth for 13 of top 20 biopharmas with obesity drug successes in 2023",
    "published": 1722434008,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 116.0,
      "2024-07-31T14:30:00+00:00": 114.9749984741211,
      "2024-07-31T15:30:00+00:00": 114.38999938964844,
      "2024-07-31T16:30:00+00:00": 113.44499969482422,
      "2024-07-31T17:30:00+00:00": 112.3458023071289,
      "2024-07-31T18:30:00+00:00": 112.81999969482422,
      "2024-07-31T19:30:00+00:00": 112.32499694824219
    },
    "sentiment": 0.9020430445671082
  },
  {
    "title": "Analyzing Merck & Co In Comparison To Competitors In Pharmaceuticals Industry",
    "published": 1722420420,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 116.0,
      "2024-07-31T14:30:00+00:00": 114.9749984741211,
      "2024-07-31T15:30:00+00:00": 114.38999938964844,
      "2024-07-31T16:30:00+00:00": 113.44499969482422,
      "2024-07-31T17:30:00+00:00": 112.3458023071289,
      "2024-07-31T18:30:00+00:00": 112.81999969482422,
      "2024-07-31T19:30:00+00:00": 112.32499694824219
    },
    "sentiment": 0.5343099236488342
  },
  {
    "title": "Bank of America Securities Reaffirms Their Buy Rating on Merck & Company (MRK)",
    "published": 1722415800,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 116.0,
      "2024-07-31T14:30:00+00:00": 114.9749984741211,
      "2024-07-31T15:30:00+00:00": 114.38999938964844,
      "2024-07-31T16:30:00+00:00": 113.44499969482422,
      "2024-07-31T17:30:00+00:00": 112.3458023071289,
      "2024-07-31T18:30:00+00:00": 112.81999969482422,
      "2024-07-31T19:30:00+00:00": 112.32499694824219
    },
    "sentiment": 0.8222776055335999
  },
  {
    "title": "Merck & Company (MRK) Gets a Buy from Truist Financial",
    "published": 1722407940,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 116.0,
      "2024-07-31T14:30:00+00:00": 114.9749984741211,
      "2024-07-31T15:30:00+00:00": 114.38999938964844,
      "2024-07-31T16:30:00+00:00": 113.44499969482422,
      "2024-07-31T17:30:00+00:00": 112.3458023071289,
      "2024-07-31T18:30:00+00:00": 112.81999969482422,
      "2024-07-31T19:30:00+00:00": 112.32499694824219
    },
    "sentiment": 0.6960911154747009
  },
  {
    "title": "Q2 2024 Merck & Co Inc Earnings Call",
    "published": 1722405514,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 116.0,
      "2024-07-31T14:30:00+00:00": 114.9749984741211,
      "2024-07-31T15:30:00+00:00": 114.38999938964844,
      "2024-07-31T16:30:00+00:00": 113.44499969482422,
      "2024-07-31T17:30:00+00:00": 112.3458023071289,
      "2024-07-31T18:30:00+00:00": 112.81999969482422,
      "2024-07-31T19:30:00+00:00": 112.32499694824219
    },
    "sentiment": 0.7987715601921082
  },
  {
    "title": "Maintaining a Buy: A Balanced View on Merck Amid Gardasil Setbacks and Long-Term Growth Prospects",
    "published": 1722401340,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 116.0,
      "2024-07-31T14:30:00+00:00": 114.9749984741211,
      "2024-07-31T15:30:00+00:00": 114.38999938964844,
      "2024-07-31T16:30:00+00:00": 113.44499969482422,
      "2024-07-31T17:30:00+00:00": 112.3458023071289,
      "2024-07-31T18:30:00+00:00": 112.81999969482422,
      "2024-07-31T19:30:00+00:00": 112.32499694824219
    },
    "sentiment": 0.8716251850128174
  },
  {
    "title": "Merck & Company (MRK) Receives a Buy from Barclays",
    "published": 1722394800,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 116.0,
      "2024-07-31T14:30:00+00:00": 114.9749984741211,
      "2024-07-31T15:30:00+00:00": 114.38999938964844,
      "2024-07-31T16:30:00+00:00": 113.44499969482422,
      "2024-07-31T17:30:00+00:00": 112.3458023071289,
      "2024-07-31T18:30:00+00:00": 112.81999969482422,
      "2024-07-31T19:30:00+00:00": 112.32499694824219
    },
    "sentiment": 0.557750940322876
  },
  {
    "title": "Merck & Co Inc (MRK) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...",
    "published": 1722387900,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 116.0,
      "2024-07-31T14:30:00+00:00": 114.9749984741211,
      "2024-07-31T15:30:00+00:00": 114.38999938964844,
      "2024-07-31T16:30:00+00:00": 113.44499969482422,
      "2024-07-31T17:30:00+00:00": 112.3458023071289,
      "2024-07-31T18:30:00+00:00": 112.81999969482422,
      "2024-07-31T19:30:00+00:00": 112.32499694824219
    },
    "sentiment": 0.953738272190094
  },
  {
    "title": "Big movers: NVIDIA slumps; P&G, Merck down, PayPal up",
    "published": 1722360610,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.8091838359832764
  },
  {
    "title": "Merck Stock Slides on Lowered Adjusted EPS Guidance",
    "published": 1722354040,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9514317512512207
  },
  {
    "title": "Merck & Co., Inc. (MRK) Q2 2024 Earnings Call Transcript",
    "published": 1722350462,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9155044555664062
  },
  {
    "title": "Merck Falls as HPV Vaccine Miss Overshadows Profit, Sales Beat",
    "published": 1722350123,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9510235786437988
  },
  {
    "title": "Merck nears seven-month low on guidance cut (update)",
    "published": 1722343500,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9281488060951233
  },
  {
    "title": "Merck is Oversold",
    "published": 1722336240,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.8592199087142944
  },
  {
    "title": "Merck cuts annual profit forecast",
    "published": 1722335561,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.962960958480835
  },
  {
    "title": "Trending : Merck 2Q Profit Beats Expectations; Fiscal Year Adjusted EPS Outlook Lowered",
    "published": 1722333748,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9379880428314209
  },
  {
    "title": "MRK Stock Earnings: Merck & Co Beats EPS, Beats Revenue for Q2 2024",
    "published": 1722333240,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.6471872925758362
  },
  {
    "title": "MRK Earnings: Merck Beats Estimates in Q2",
    "published": 1722326640,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.6848158240318298
  },
  {
    "title": "Pfizer,  JetBlue, PayPal rise premarket; Merck, CrowdStrike, Diageo fall",
    "published": 1722324506,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9311999678611755
  },
  {
    "title": "Merck Swings to 2Q Profit Ahead of Views, Lowers FY24 Adjusted EPS Outlook",
    "published": 1722323936,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9351714849472046
  },
  {
    "title": "Merck returns to profit in Q2",
    "published": 1722323020,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9357920289039612
  },
  {
    "title": "Merck powers to Q2 beat on cancer drug Keytruda",
    "published": 1722320340,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.8060121536254883
  },
  {
    "title": "Merck in charts: KEYTRUDA shows consistent growth past 3 years, rises ~16% in Q2",
    "published": 1722318900,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9504752159118652
  },
  {
    "title": "Merck reports Q2 KEYTRUDA sales grew 16% to $7.3B",
    "published": 1722317700,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9583466053009033
  },
  {
    "title": "Merck reports Q2 adjusted EPS $2.28, consensus $2.15",
    "published": 1722317460,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.4492361843585968
  },
  {
    "title": "Deutsche Bank  Sticks to Its Buy Rating for Merck KGaA (0O14)",
    "published": 1722315960,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.8642938733100891
  },
  {
    "title": "Notable Tuesday Option Activity: MRK, PG, GEHC",
    "published": 1722302640,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 123.4800033569336,
      "2024-07-30T14:30:00+00:00": 117.02999877929688,
      "2024-07-30T15:30:00+00:00": 115.41000366210938,
      "2024-07-30T16:30:00+00:00": 115.57499694824219,
      "2024-07-30T17:30:00+00:00": 116.61000061035156,
      "2024-07-30T18:30:00+00:00": 115.0199966430664,
      "2024-07-30T19:30:00+00:00": 115.91999816894531
    },
    "sentiment": 0.9195274710655212
  },
  {
    "title": "Merck Q2 Earnings Preview: Beat/raise likely with focus on Winrevair launch",
    "published": 1722215340,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 125.7750015258789,
      "2024-07-29T14:30:00+00:00": 126.47000122070312,
      "2024-07-29T15:30:00+00:00": 127.04000091552734,
      "2024-07-29T16:30:00+00:00": 127.62000274658203,
      "2024-07-29T17:30:00+00:00": 127.5199966430664,
      "2024-07-29T18:30:00+00:00": 127.21299743652344,
      "2024-07-29T19:30:00+00:00": 127.34500122070312
    },
    "sentiment": 0.8396111726760864
  },
  {
    "title": "Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships",
    "published": 1722169800,
    "day_prices": {},
    "sentiment": 0.7809173464775085
  },
  {
    "title": "Merck and Pfizer combination therapy recommended for European approval",
    "published": 1722005880,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 127.23500061035156,
      "2024-07-26T14:30:00+00:00": 126.95999908447266,
      "2024-07-26T15:30:00+00:00": 126.08000183105469,
      "2024-07-26T16:30:00+00:00": 125.58000183105469,
      "2024-07-26T17:30:00+00:00": 125.56999969482422,
      "2024-07-26T18:30:00+00:00": 125.9749984741211,
      "2024-07-26T19:30:00+00:00": 125.94499969482422
    },
    "sentiment": 0.669179379940033
  },
  {
    "title": "Merck Receives Positive EU CHMP Opinion for KEYTRUDA\u00ae (pembrolizumab) Plus Padcev\u00ae (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma",
    "published": 1721991000,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 127.23500061035156,
      "2024-07-26T14:30:00+00:00": 126.95999908447266,
      "2024-07-26T15:30:00+00:00": 126.08000183105469,
      "2024-07-26T16:30:00+00:00": 125.58000183105469,
      "2024-07-26T17:30:00+00:00": 125.56999969482422,
      "2024-07-26T18:30:00+00:00": 125.9749984741211,
      "2024-07-26T19:30:00+00:00": 125.94499969482422
    },
    "sentiment": 0.9404113292694092
  },
  {
    "title": "Merck KGaA (0O14) Gets a Buy from J.P. Morgan",
    "published": 1721964360,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 127.23500061035156,
      "2024-07-26T14:30:00+00:00": 126.95999908447266,
      "2024-07-26T15:30:00+00:00": 126.08000183105469,
      "2024-07-26T16:30:00+00:00": 125.58000183105469,
      "2024-07-26T17:30:00+00:00": 125.56999969482422,
      "2024-07-26T18:30:00+00:00": 125.9749984741211,
      "2024-07-26T19:30:00+00:00": 125.94499969482422
    },
    "sentiment": 0.8851937651634216
  },
  {
    "title": "Merck & Co's Options: A Look at What the Big Money is Thinking",
    "published": 1721956680,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 127.23500061035156,
      "2024-07-26T14:30:00+00:00": 126.95999908447266,
      "2024-07-26T15:30:00+00:00": 126.08000183105469,
      "2024-07-26T16:30:00+00:00": 125.58000183105469,
      "2024-07-26T17:30:00+00:00": 125.56999969482422,
      "2024-07-26T18:30:00+00:00": 125.9749984741211,
      "2024-07-26T19:30:00+00:00": 125.94499969482422
    },
    "sentiment": 0.9309603571891785
  },
  {
    "title": "RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus",
    "published": 1721845955,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 124.97000122070312,
      "2024-07-24T14:30:00+00:00": 125.09500122070312,
      "2024-07-24T15:30:00+00:00": 125.23500061035156,
      "2024-07-24T16:30:00+00:00": 125.80999755859375,
      "2024-07-24T17:30:00+00:00": 125.7300033569336,
      "2024-07-24T18:30:00+00:00": 125.63999938964844,
      "2024-07-24T19:30:00+00:00": 125.62000274658203
    },
    "sentiment": 0.6931594014167786
  },
  {
    "title": "MSD reports positive topline data from Phase IIb/III RSV trial in infants",
    "published": 1721812360,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 124.97000122070312,
      "2024-07-24T14:30:00+00:00": 125.09500122070312,
      "2024-07-24T15:30:00+00:00": 125.23500061035156,
      "2024-07-24T16:30:00+00:00": 125.80999755859375,
      "2024-07-24T17:30:00+00:00": 125.7300033569336,
      "2024-07-24T18:30:00+00:00": 125.63999938964844,
      "2024-07-24T19:30:00+00:00": 125.62000274658203
    },
    "sentiment": 0.9490051865577698
  },
  {
    "title": "Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants",
    "published": 1721761440,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 124.98999786376953,
      "2024-07-23T14:30:00+00:00": 124.4800033569336,
      "2024-07-23T15:30:00+00:00": 124.81009674072266,
      "2024-07-23T16:30:00+00:00": 124.9000015258789,
      "2024-07-23T17:30:00+00:00": 124.76000213623047,
      "2024-07-23T18:30:00+00:00": 124.80500030517578,
      "2024-07-23T19:30:00+00:00": 124.63999938964844
    },
    "sentiment": 0.8693684935569763
  },
  {
    "title": "Should You Buy, Sell or Hold Merck (MRK) Ahead of Q2 Earnings?",
    "published": 1721747820,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 124.98999786376953,
      "2024-07-23T14:30:00+00:00": 124.4800033569336,
      "2024-07-23T15:30:00+00:00": 124.81009674072266,
      "2024-07-23T16:30:00+00:00": 124.9000015258789,
      "2024-07-23T17:30:00+00:00": 124.76000213623047,
      "2024-07-23T18:30:00+00:00": 124.80500030517578,
      "2024-07-23T19:30:00+00:00": 124.63999938964844
    },
    "sentiment": 0.9437016248703003
  },
  {
    "title": "Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 78% of the company",
    "published": 1721736021,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 124.98999786376953,
      "2024-07-23T14:30:00+00:00": 124.4800033569336,
      "2024-07-23T15:30:00+00:00": 124.81009674072266,
      "2024-07-23T16:30:00+00:00": 124.9000015258789,
      "2024-07-23T17:30:00+00:00": 124.76000213623047,
      "2024-07-23T18:30:00+00:00": 124.80500030517578,
      "2024-07-23T19:30:00+00:00": 124.63999938964844
    },
    "sentiment": 0.956017255783081
  },
  {
    "title": "Merck claims late-stage study success for RSV antibody",
    "published": 1721732460,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 124.98999786376953,
      "2024-07-23T14:30:00+00:00": 124.4800033569336,
      "2024-07-23T15:30:00+00:00": 124.81009674072266,
      "2024-07-23T16:30:00+00:00": 124.9000015258789,
      "2024-07-23T17:30:00+00:00": 124.76000213623047,
      "2024-07-23T18:30:00+00:00": 124.80500030517578,
      "2024-07-23T19:30:00+00:00": 124.63999938964844
    },
    "sentiment": 0.9259085059165955
  },
  {
    "title": "Video: Dow Analyst Moves: MRK",
    "published": 1721731920,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 124.98999786376953,
      "2024-07-23T14:30:00+00:00": 124.4800033569336,
      "2024-07-23T15:30:00+00:00": 124.81009674072266,
      "2024-07-23T16:30:00+00:00": 124.9000015258789,
      "2024-07-23T17:30:00+00:00": 124.76000213623047,
      "2024-07-23T18:30:00+00:00": 124.80500030517578,
      "2024-07-23T19:30:00+00:00": 124.63999938964844
    },
    "sentiment": 0.921454131603241
  },
  {
    "title": "Merck KGaA (0O14) Receives a Buy from Barclays",
    "published": 1721719800,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 124.98999786376953,
      "2024-07-23T14:30:00+00:00": 124.4800033569336,
      "2024-07-23T15:30:00+00:00": 124.81009674072266,
      "2024-07-23T16:30:00+00:00": 124.9000015258789,
      "2024-07-23T17:30:00+00:00": 124.76000213623047,
      "2024-07-23T18:30:00+00:00": 124.80500030517578,
      "2024-07-23T19:30:00+00:00": 124.63999938964844
    },
    "sentiment": 0.7836637496948242
  },
  {
    "title": "Merck's RSV drug meets main goals of mid-to-late stage trial",
    "published": 1721717739,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 124.98999786376953,
      "2024-07-23T14:30:00+00:00": 124.4800033569336,
      "2024-07-23T15:30:00+00:00": 124.81009674072266,
      "2024-07-23T16:30:00+00:00": 124.9000015258789,
      "2024-07-23T17:30:00+00:00": 124.76000213623047,
      "2024-07-23T18:30:00+00:00": 124.80500030517578,
      "2024-07-23T19:30:00+00:00": 124.63999938964844
    },
    "sentiment": 0.5563735365867615
  },
  {
    "title": "Merck reports 'positive' results from Phase 2b/3 trial of clesrovimab",
    "published": 1721713740,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 124.98999786376953,
      "2024-07-23T14:30:00+00:00": 124.4800033569336,
      "2024-07-23T15:30:00+00:00": 124.81009674072266,
      "2024-07-23T16:30:00+00:00": 124.9000015258789,
      "2024-07-23T17:30:00+00:00": 124.76000213623047,
      "2024-07-23T18:30:00+00:00": 124.80500030517578,
      "2024-07-23T19:30:00+00:00": 124.63999938964844
    },
    "sentiment": 0.943709135055542
  },
  {
    "title": "Merck & Co. Poised for Growth: Strong Q2 Performance and Promising Pipeline Fuel Buy Rating",
    "published": 1721612820,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 125.94999694824219,
      "2024-07-22T14:30:00+00:00": 125.83999633789062,
      "2024-07-22T15:30:00+00:00": 125.66000366210938,
      "2024-07-22T16:30:00+00:00": 125.66000366210938,
      "2024-07-22T17:30:00+00:00": 126.0,
      "2024-07-22T18:30:00+00:00": 125.72000122070312,
      "2024-07-22T19:30:00+00:00": 125.55999755859375
    },
    "sentiment": 0.950093686580658
  },
  {
    "title": "Notable Friday Option Activity: MRK, ALL, HUM",
    "published": 1721391600,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 125.30000305175781,
      "2024-07-19T14:30:00+00:00": 126.16500091552734,
      "2024-07-19T15:30:00+00:00": 125.9000015258789,
      "2024-07-19T16:30:00+00:00": 126.18000030517578,
      "2024-07-19T17:30:00+00:00": 126.07499694824219,
      "2024-07-19T18:30:00+00:00": 125.86000061035156,
      "2024-07-19T19:30:00+00:00": 125.80999755859375
    },
    "sentiment": 0.8456821441650391
  },
  {
    "title": "Merck & Co Inc. DCF Valuation: Is The Stock Undervalued?",
    "published": 1721374860,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 125.30000305175781,
      "2024-07-19T14:30:00+00:00": 126.16500091552734,
      "2024-07-19T15:30:00+00:00": 125.9000015258789,
      "2024-07-19T16:30:00+00:00": 126.18000030517578,
      "2024-07-19T17:30:00+00:00": 126.07499694824219,
      "2024-07-19T18:30:00+00:00": 125.86000061035156,
      "2024-07-19T19:30:00+00:00": 125.80999755859375
    },
    "sentiment": 0.5963130593299866
  },
  {
    "title": "Merck & Co's Options Frenzy: What You Need to Know",
    "published": 1721295420,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 125.0199966430664,
      "2024-07-18T14:30:00+00:00": 124.44999694824219,
      "2024-07-18T15:30:00+00:00": 123.5,
      "2024-07-18T16:30:00+00:00": 123.0,
      "2024-07-18T17:30:00+00:00": 123.04000091552734,
      "2024-07-18T18:30:00+00:00": 123.79000091552734,
      "2024-07-18T19:30:00+00:00": 124.08000183105469
    },
    "sentiment": 0.9393965005874634
  },
  {
    "title": "GLOBAL BROKER RATINGS: Oddo cuts Lufthansa, UBS raises Credit Agricole",
    "published": 1721287320,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 125.0199966430664,
      "2024-07-18T14:30:00+00:00": 124.44999694824219,
      "2024-07-18T15:30:00+00:00": 123.5,
      "2024-07-18T16:30:00+00:00": 123.0,
      "2024-07-18T17:30:00+00:00": 123.04000091552734,
      "2024-07-18T18:30:00+00:00": 123.79000091552734,
      "2024-07-18T19:30:00+00:00": 124.08000183105469
    },
    "sentiment": 0.9025897979736328
  },
  {
    "title": "Merck KGaA to acquire chip equipment supplier Unity-SC",
    "published": 1721278440,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 125.0199966430664,
      "2024-07-18T14:30:00+00:00": 124.44999694824219,
      "2024-07-18T15:30:00+00:00": 123.5,
      "2024-07-18T16:30:00+00:00": 123.0,
      "2024-07-18T17:30:00+00:00": 123.04000091552734,
      "2024-07-18T18:30:00+00:00": 123.79000091552734,
      "2024-07-18T19:30:00+00:00": 124.08000183105469
    },
    "sentiment": 0.9100676774978638
  },
  {
    "title": "Merck Gets Legal Victory As Appeals Court Dismisses Shingles Vaccine Some 1,200 Lawsuits",
    "published": 1721268000,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 125.0199966430664,
      "2024-07-18T14:30:00+00:00": 124.44999694824219,
      "2024-07-18T15:30:00+00:00": 123.5,
      "2024-07-18T16:30:00+00:00": 123.0,
      "2024-07-18T17:30:00+00:00": 123.04000091552734,
      "2024-07-18T18:30:00+00:00": 123.79000091552734,
      "2024-07-18T19:30:00+00:00": 124.08000183105469
    },
    "sentiment": 0.6729404926300049
  },
  {
    "title": "Evaluating Merck & Co Against Peers In Pharmaceuticals Industry",
    "published": 1721210580,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 125.47000122070312,
      "2024-07-17T14:30:00+00:00": 126.31999969482422,
      "2024-07-17T15:30:00+00:00": 125.4000015258789,
      "2024-07-17T16:30:00+00:00": 125.8469009399414,
      "2024-07-17T17:30:00+00:00": 125.91000366210938,
      "2024-07-17T18:30:00+00:00": 125.83999633789062,
      "2024-07-17T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.7711069583892822
  },
  {
    "title": "Jefferies Reaffirms Their Buy Rating on Merck KGaA (0O14)",
    "published": 1721186760,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 125.47000122070312,
      "2024-07-17T14:30:00+00:00": 126.31999969482422,
      "2024-07-17T15:30:00+00:00": 125.4000015258789,
      "2024-07-17T16:30:00+00:00": 125.8469009399414,
      "2024-07-17T17:30:00+00:00": 125.91000366210938,
      "2024-07-17T18:30:00+00:00": 125.83999633789062,
      "2024-07-17T19:30:00+00:00": 125.81999969482422
    },
    "sentiment": 0.8137532472610474
  },
  {
    "title": "Merck: to present its advances in HIV at AIDS 24",
    "published": 1721124918,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 127.87000274658203,
      "2024-07-16T14:30:00+00:00": 128.46499633789062,
      "2024-07-16T15:30:00+00:00": 128.3000030517578,
      "2024-07-16T16:30:00+00:00": 126.94000244140625,
      "2024-07-16T17:30:00+00:00": 126.12999725341797,
      "2024-07-16T18:30:00+00:00": 126.01000213623047,
      "2024-07-16T19:30:00+00:00": 125.72000122070312
    },
    "sentiment": 0.7057464122772217
  },
  {
    "title": "The Zacks Analyst Blog Highlights Exxon  Mobil, Merck & Co, Qualcomm and Armanino Foods of Distinction",
    "published": 1721037660,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 128.0,
      "2024-07-15T14:30:00+00:00": 127.76000213623047,
      "2024-07-15T15:30:00+00:00": 128.0,
      "2024-07-15T16:30:00+00:00": 127.88999938964844,
      "2024-07-15T17:30:00+00:00": 127.61499786376953,
      "2024-07-15T18:30:00+00:00": 127.46499633789062,
      "2024-07-15T19:30:00+00:00": 128.11000061035156
    },
    "sentiment": 0.9211998581886292
  },
  {
    "title": "SCD: Still A Good Fund, But The Buy Case Is Weakening (Rating Downgrade)",
    "published": 1720953637,
    "day_prices": {},
    "sentiment": 0.8663319945335388
  },
  {
    "title": "Healthcare sector at an 'inflection point': Strategist",
    "published": 1720818241,
    "day_prices": {
      "2024-07-12T13:30:00+00:00": 129.39999389648438,
      "2024-07-12T14:30:00+00:00": 129.72999572753906,
      "2024-07-12T15:30:00+00:00": 128.55999755859375,
      "2024-07-12T16:30:00+00:00": 128.25,
      "2024-07-12T17:30:00+00:00": 128.1300048828125,
      "2024-07-12T18:30:00+00:00": 127.97000122070312,
      "2024-07-12T19:30:00+00:00": 128.14999389648438
    },
    "sentiment": 0.9225196838378906
  },
  {
    "title": "MSD closes $1.3bn EyeBio acquisition, plans pivotal trial for lead asset",
    "published": 1720798413,
    "day_prices": {
      "2024-07-12T13:30:00+00:00": 129.39999389648438,
      "2024-07-12T14:30:00+00:00": 129.72999572753906,
      "2024-07-12T15:30:00+00:00": 128.55999755859375,
      "2024-07-12T16:30:00+00:00": 128.25,
      "2024-07-12T17:30:00+00:00": 128.1300048828125,
      "2024-07-12T18:30:00+00:00": 127.97000122070312,
      "2024-07-12T19:30:00+00:00": 128.14999389648438
    },
    "sentiment": 0.6698859930038452
  },
  {
    "title": "Merck: completes acquisition of EyeBio",
    "published": 1720775255,
    "day_prices": {
      "2024-07-12T13:30:00+00:00": 129.39999389648438,
      "2024-07-12T14:30:00+00:00": 129.72999572753906,
      "2024-07-12T15:30:00+00:00": 128.55999755859375,
      "2024-07-12T16:30:00+00:00": 128.25,
      "2024-07-12T17:30:00+00:00": 128.1300048828125,
      "2024-07-12T18:30:00+00:00": 127.97000122070312,
      "2024-07-12T19:30:00+00:00": 128.14999389648438
    },
    "sentiment": 0.895167350769043
  },
  {
    "title": "Merck: Positive Developments, But Watch The Q2 Earnings",
    "published": 1720760216,
    "day_prices": {
      "2024-07-12T13:30:00+00:00": 129.39999389648438,
      "2024-07-12T14:30:00+00:00": 129.72999572753906,
      "2024-07-12T15:30:00+00:00": 128.55999755859375,
      "2024-07-12T16:30:00+00:00": 128.25,
      "2024-07-12T17:30:00+00:00": 128.1300048828125,
      "2024-07-12T18:30:00+00:00": 127.97000122070312,
      "2024-07-12T19:30:00+00:00": 128.14999389648438
    },
    "sentiment": 0.8226276636123657
  },
  {
    "title": "Prelude and MSD partner to trial PRT3789 and Keytruda combination",
    "published": 1720608782,
    "day_prices": {
      "2024-07-10T13:30:00+00:00": 125.87999725341797,
      "2024-07-10T14:30:00+00:00": 126.87000274658203,
      "2024-07-10T15:30:00+00:00": 127.08000183105469,
      "2024-07-10T16:30:00+00:00": 127.0250015258789,
      "2024-07-10T17:30:00+00:00": 127.23999786376953,
      "2024-07-10T18:30:00+00:00": 126.94999694824219,
      "2024-07-10T19:30:00+00:00": 126.80000305175781
    },
    "sentiment": 0.6209646463394165
  },
  {
    "title": "GLOBAL BROKER RATINGS: Citigroup raises Next, BofA cuts Mastercard",
    "published": 1720594860,
    "day_prices": {
      "2024-07-10T13:30:00+00:00": 125.87999725341797,
      "2024-07-10T14:30:00+00:00": 126.87000274658203,
      "2024-07-10T15:30:00+00:00": 127.08000183105469,
      "2024-07-10T16:30:00+00:00": 127.0250015258789,
      "2024-07-10T17:30:00+00:00": 127.23999786376953,
      "2024-07-10T18:30:00+00:00": 126.94999694824219,
      "2024-07-10T19:30:00+00:00": 126.80000305175781
    },
    "sentiment": 0.8432796001434326
  },
  {
    "title": "Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business",
    "published": 1720528200,
    "day_prices": {
      "2024-07-09T13:30:00+00:00": 125.23999786376953,
      "2024-07-09T14:30:00+00:00": 124.7699966430664,
      "2024-07-09T15:30:00+00:00": 125.23999786376953,
      "2024-07-09T16:30:00+00:00": 125.36499786376953,
      "2024-07-09T17:30:00+00:00": 125.83999633789062,
      "2024-07-09T18:30:00+00:00": 125.58999633789062,
      "2024-07-09T19:30:00+00:00": 125.77999877929688
    },
    "sentiment": 0.8574122190475464
  },
  {
    "title": "Merck: acquires aquatics division of Elanco Animal Health",
    "published": 1720520118,
    "day_prices": {
      "2024-07-09T13:30:00+00:00": 125.23999786376953,
      "2024-07-09T14:30:00+00:00": 124.7699966430664,
      "2024-07-09T15:30:00+00:00": 125.23999786376953,
      "2024-07-09T16:30:00+00:00": 125.36499786376953,
      "2024-07-09T17:30:00+00:00": 125.83999633789062,
      "2024-07-09T18:30:00+00:00": 125.58999633789062,
      "2024-07-09T19:30:00+00:00": 125.77999877929688
    },
    "sentiment": 0.9282341599464417
  },
  {
    "title": "ASNA and Athinia\u00ae collaborate to boost semiconductor manufacturing yields through improved data sharing and traceability of subcomponent parts",
    "published": 1720426500,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 126.80000305175781,
      "2024-07-08T14:30:00+00:00": 126.61000061035156,
      "2024-07-08T15:30:00+00:00": 125.88999938964844,
      "2024-07-08T16:30:00+00:00": 125.68000030517578,
      "2024-07-08T17:30:00+00:00": 125.63999938964844,
      "2024-07-08T18:30:00+00:00": 125.86489868164062,
      "2024-07-08T19:30:00+00:00": 125.8499984741211
    },
    "sentiment": 0.930830180644989
  },
  {
    "title": "Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients",
    "published": 1720181390,
    "day_prices": {
      "2024-07-05T13:30:00+00:00": 126.52999877929688,
      "2024-07-05T14:30:00+00:00": 125.70999908447266,
      "2024-07-05T15:30:00+00:00": 126.11000061035156,
      "2024-07-05T16:30:00+00:00": 125.70999908447266,
      "2024-07-05T17:30:00+00:00": 125.2699966430664,
      "2024-07-05T18:30:00+00:00": 125.70999908447266,
      "2024-07-05T19:30:00+00:00": 126.08000183105469
    },
    "sentiment": 0.7294076681137085
  },
  {
    "title": "mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment",
    "published": 1719941898,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 128.2100067138672,
      "2024-07-02T14:30:00+00:00": 127.2249984741211,
      "2024-07-02T15:30:00+00:00": 127.44499969482422,
      "2024-07-02T16:30:00+00:00": 127.3499984741211,
      "2024-07-02T17:30:00+00:00": 127.18000030517578,
      "2024-07-02T18:30:00+00:00": 127.7300033569336,
      "2024-07-02T19:30:00+00:00": 127.68000030517578
    },
    "sentiment": 0.6752479672431946
  },
  {
    "title": "N-Power Medicine partners with MSD to expand access to oncology clinical trials",
    "published": 1719916373,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 128.2100067138672,
      "2024-07-02T14:30:00+00:00": 127.2249984741211,
      "2024-07-02T15:30:00+00:00": 127.44499969482422,
      "2024-07-02T16:30:00+00:00": 127.3499984741211,
      "2024-07-02T17:30:00+00:00": 127.18000030517578,
      "2024-07-02T18:30:00+00:00": 127.7300033569336,
      "2024-07-02T19:30:00+00:00": 127.68000030517578
    },
    "sentiment": 0.8864652514457703
  },
  {
    "title": "Orion to hand over exclusive rights to MSD for prostate cancer therapy",
    "published": 1719850431,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 125.37999725341797,
      "2024-07-01T14:30:00+00:00": 128.7899932861328,
      "2024-07-01T15:30:00+00:00": 128.3300018310547,
      "2024-07-01T16:30:00+00:00": 128.3699951171875,
      "2024-07-01T17:30:00+00:00": 127.95999908447266,
      "2024-07-01T18:30:00+00:00": 127.83000183105469,
      "2024-07-01T19:30:00+00:00": 127.9800033569336
    },
    "sentiment": 0.714028537273407
  },
  {
    "title": "Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30",
    "published": 1719830700,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 125.37999725341797,
      "2024-07-01T14:30:00+00:00": 128.7899932861328,
      "2024-07-01T15:30:00+00:00": 128.3300018310547,
      "2024-07-01T16:30:00+00:00": 128.3699951171875,
      "2024-07-01T17:30:00+00:00": 127.95999908447266,
      "2024-07-01T18:30:00+00:00": 127.83000183105469,
      "2024-07-01T19:30:00+00:00": 127.9800033569336
    },
    "sentiment": 0.9219596982002258
  },
  {
    "title": "Merck, Orion Convert Collaboration Into Exclusive License",
    "published": 1719824813,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 125.37999725341797,
      "2024-07-01T14:30:00+00:00": 128.7899932861328,
      "2024-07-01T15:30:00+00:00": 128.3300018310547,
      "2024-07-01T16:30:00+00:00": 128.3699951171875,
      "2024-07-01T17:30:00+00:00": 127.95999908447266,
      "2024-07-01T18:30:00+00:00": 127.83000183105469,
      "2024-07-01T19:30:00+00:00": 127.9800033569336
    },
    "sentiment": 0.897569477558136
  },
  {
    "title": "NuCana plunges amid trial setback for cancer drug",
    "published": 1725010620,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 117.2699966430664,
      "2024-08-30T14:30:00+00:00": 117.97000122070312,
      "2024-08-30T15:30:00+00:00": 117.71499633789062,
      "2024-08-30T16:30:00+00:00": 117.5199966430664,
      "2024-08-30T17:30:00+00:00": 117.56999969482422,
      "2024-08-30T18:30:00+00:00": 117.8301010131836,
      "2024-08-30T19:30:00+00:00": 118.0199966430664
    },
    "sentiment": 0.962063729763031
  },
  {
    "title": "NuCana gains despite trial setback for cancer drug",
    "published": 1725009660,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 117.2699966430664,
      "2024-08-30T14:30:00+00:00": 117.97000122070312,
      "2024-08-30T15:30:00+00:00": 117.71499633789062,
      "2024-08-30T16:30:00+00:00": 117.5199966430664,
      "2024-08-30T17:30:00+00:00": 117.56999969482422,
      "2024-08-30T18:30:00+00:00": 117.8301010131836,
      "2024-08-30T19:30:00+00:00": 118.0199966430664
    },
    "sentiment": 0.8997931480407715
  },
  {
    "title": "Behind the Scenes of Merck & Co's Latest Options Trends",
    "published": 1724998260,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 117.2699966430664,
      "2024-08-30T14:30:00+00:00": 117.97000122070312,
      "2024-08-30T15:30:00+00:00": 117.71499633789062,
      "2024-08-30T16:30:00+00:00": 117.5199966430664,
      "2024-08-30T17:30:00+00:00": 117.56999969482422,
      "2024-08-30T18:30:00+00:00": 117.8301010131836,
      "2024-08-30T19:30:00+00:00": 118.0199966430664
    },
    "sentiment": 0.9342905282974243
  },
  {
    "title": "MSD discontinues two Phase III Keytruda trials",
    "published": 1724938389,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 117.93000030517578,
      "2024-08-29T14:30:00+00:00": 117.62999725341797,
      "2024-08-29T15:30:00+00:00": 117.68000030517578,
      "2024-08-29T16:30:00+00:00": 117.94499969482422,
      "2024-08-29T17:30:00+00:00": 118.0,
      "2024-08-29T18:30:00+00:00": 117.8499984741211,
      "2024-08-29T19:30:00+00:00": 117.80999755859375
    },
    "sentiment": 0.8563370108604431
  },
  {
    "title": "Merck discontinuing Phase 3 KEYNOTE-867, KEYNOTE-630 trials",
    "published": 1724930220,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 117.93000030517578,
      "2024-08-29T14:30:00+00:00": 117.62999725341797,
      "2024-08-29T15:30:00+00:00": 117.68000030517578,
      "2024-08-29T16:30:00+00:00": 117.94499969482422,
      "2024-08-29T17:30:00+00:00": 118.0,
      "2024-08-29T18:30:00+00:00": 117.8499984741211,
      "2024-08-29T19:30:00+00:00": 117.80999755859375
    },
    "sentiment": 0.8715998530387878
  },
  {
    "title": "Merck to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference",
    "published": 1724928300,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 117.93000030517578,
      "2024-08-29T14:30:00+00:00": 117.62999725341797,
      "2024-08-29T15:30:00+00:00": 117.68000030517578,
      "2024-08-29T16:30:00+00:00": 117.94499969482422,
      "2024-08-29T17:30:00+00:00": 118.0,
      "2024-08-29T18:30:00+00:00": 117.8499984741211,
      "2024-08-29T19:30:00+00:00": 117.80999755859375
    },
    "sentiment": 0.8275839686393738
  },
  {
    "title": "AbbVie: Promising Developments On IBD Treatments",
    "published": 1724927095,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 117.93000030517578,
      "2024-08-29T14:30:00+00:00": 117.62999725341797,
      "2024-08-29T15:30:00+00:00": 117.68000030517578,
      "2024-08-29T16:30:00+00:00": 117.94499969482422,
      "2024-08-29T17:30:00+00:00": 118.0,
      "2024-08-29T18:30:00+00:00": 117.8499984741211,
      "2024-08-29T19:30:00+00:00": 117.80999755859375
    },
    "sentiment": 0.9448575377464294
  },
  {
    "title": "Merck discontinues two Keytruda trials for lung and skin cancer",
    "published": 1724917500,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 117.93000030517578,
      "2024-08-29T14:30:00+00:00": 117.62999725341797,
      "2024-08-29T15:30:00+00:00": 117.68000030517578,
      "2024-08-29T16:30:00+00:00": 117.94499969482422,
      "2024-08-29T17:30:00+00:00": 118.0,
      "2024-08-29T18:30:00+00:00": 117.8499984741211,
      "2024-08-29T19:30:00+00:00": 117.80999755859375
    },
    "sentiment": 0.5852890014648438
  },
  {
    "title": "Merck stops two more cancer trials over poor results",
    "published": 1724911200,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 117.93000030517578,
      "2024-08-29T14:30:00+00:00": 117.62999725341797,
      "2024-08-29T15:30:00+00:00": 117.68000030517578,
      "2024-08-29T16:30:00+00:00": 117.94499969482422,
      "2024-08-29T17:30:00+00:00": 118.0,
      "2024-08-29T18:30:00+00:00": 117.8499984741211,
      "2024-08-29T19:30:00+00:00": 117.80999755859375
    },
    "sentiment": 0.9609310626983643
  },
  {
    "title": "MSD commences Phase III trial of thrombocythemia treatment",
    "published": 1724835144,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 116.5999984741211,
      "2024-08-28T14:30:00+00:00": 117.76499938964844,
      "2024-08-28T15:30:00+00:00": 117.93000030517578,
      "2024-08-28T16:30:00+00:00": 117.63999938964844,
      "2024-08-28T17:30:00+00:00": 117.37000274658203,
      "2024-08-28T18:30:00+00:00": 117.04000091552734,
      "2024-08-28T19:30:00+00:00": 117.25
    },
    "sentiment": 0.848749041557312
  },
  {
    "title": "Dow Jones Industrial Average Pares Recent Gains As Investors Take A Pause",
    "published": 1724817000,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 116.5999984741211,
      "2024-08-28T14:30:00+00:00": 117.76499938964844,
      "2024-08-28T15:30:00+00:00": 117.93000030517578,
      "2024-08-28T16:30:00+00:00": 117.63999938964844,
      "2024-08-28T17:30:00+00:00": 117.37000274658203,
      "2024-08-28T18:30:00+00:00": 117.04000091552734,
      "2024-08-28T19:30:00+00:00": 117.25
    },
    "sentiment": 0.518212616443634
  },
  {
    "title": "Do Options Traders Know Something About Merck (MRK) Stock We Don't?",
    "published": 1724763120,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 116.2699966430664,
      "2024-08-27T14:30:00+00:00": 115.6500015258789,
      "2024-08-27T15:30:00+00:00": 115.68000030517578,
      "2024-08-27T16:30:00+00:00": 115.38999938964844,
      "2024-08-27T17:30:00+00:00": 115.58999633789062,
      "2024-08-27T18:30:00+00:00": 115.87000274658203,
      "2024-08-27T19:30:00+00:00": 115.97000122070312
    },
    "sentiment": 0.9205400347709656
  },
  {
    "title": "Merck Announces Phase 3 Trial Initiation for Bomedemstat, an Investigational Candidate for the Treatment of Certain Patients With Essential Thrombocythemia",
    "published": 1724755500,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 116.2699966430664,
      "2024-08-27T14:30:00+00:00": 115.6500015258789,
      "2024-08-27T15:30:00+00:00": 115.68000030517578,
      "2024-08-27T16:30:00+00:00": 115.38999938964844,
      "2024-08-27T17:30:00+00:00": 115.58999633789062,
      "2024-08-27T18:30:00+00:00": 115.87000274658203,
      "2024-08-27T19:30:00+00:00": 115.97000122070312
    },
    "sentiment": 0.8673843741416931
  },
  {
    "title": "GI Innovation and MSD partner for trial of GI-102 and Keytruda regimen for cancer",
    "published": 1724751149,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 116.2699966430664,
      "2024-08-27T14:30:00+00:00": 115.6500015258789,
      "2024-08-27T15:30:00+00:00": 115.68000030517578,
      "2024-08-27T16:30:00+00:00": 115.38999938964844,
      "2024-08-27T17:30:00+00:00": 115.58999633789062,
      "2024-08-27T18:30:00+00:00": 115.87000274658203,
      "2024-08-27T19:30:00+00:00": 115.97000122070312
    },
    "sentiment": 0.5484501123428345
  },
  {
    "title": "Merck: Phase 3 trial launched",
    "published": 1724747956,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 116.2699966430664,
      "2024-08-27T14:30:00+00:00": 115.6500015258789,
      "2024-08-27T15:30:00+00:00": 115.68000030517578,
      "2024-08-27T16:30:00+00:00": 115.38999938964844,
      "2024-08-27T17:30:00+00:00": 115.58999633789062,
      "2024-08-27T18:30:00+00:00": 115.87000274658203,
      "2024-08-27T19:30:00+00:00": 115.97000122070312
    },
    "sentiment": 0.8478686213493347
  },
  {
    "title": "Merck & Co., Inc. (MRK): A Good Undervalued Stock to Invest In Now",
    "published": 1724688043,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 116.7300033569336,
      "2024-08-26T14:30:00+00:00": 117.2300033569336,
      "2024-08-26T15:30:00+00:00": 116.83999633789062,
      "2024-08-26T16:30:00+00:00": 116.55999755859375,
      "2024-08-26T17:30:00+00:00": 116.45999908447266,
      "2024-08-26T18:30:00+00:00": 116.38500213623047,
      "2024-08-26T19:30:00+00:00": 116.37000274658203
    },
    "sentiment": 0.7087429165840149
  },
  {
    "title": "Merck Receives European Commission Approval for WINREVAIR\u2122 (sotatercept) in Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, for the Treatment of PAH in Adult Patients With Functional Class II-III",
    "published": 1724669100,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 116.7300033569336,
      "2024-08-26T14:30:00+00:00": 117.2300033569336,
      "2024-08-26T15:30:00+00:00": 116.83999633789062,
      "2024-08-26T16:30:00+00:00": 116.55999755859375,
      "2024-08-26T17:30:00+00:00": 116.45999908447266,
      "2024-08-26T18:30:00+00:00": 116.38500213623047,
      "2024-08-26T19:30:00+00:00": 116.37000274658203
    },
    "sentiment": 0.9244152307510376
  },
  {
    "title": "Merck Receives European Commission Approval for WINREVAIR? (sotatercept) in Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, for the Treatment of PAH in Adult Patients With Functional Class II-III",
    "published": 1724654700,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 116.7300033569336,
      "2024-08-26T14:30:00+00:00": 117.2300033569336,
      "2024-08-26T15:30:00+00:00": 116.83999633789062,
      "2024-08-26T16:30:00+00:00": 116.55999755859375,
      "2024-08-26T17:30:00+00:00": 116.45999908447266,
      "2024-08-26T18:30:00+00:00": 116.38500213623047,
      "2024-08-26T19:30:00+00:00": 116.37000274658203
    },
    "sentiment": 0.9205535054206848
  },
  {
    "title": "Merck: oncology trial with Korea's GI Innovation",
    "published": 1724647152,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 116.7300033569336,
      "2024-08-26T14:30:00+00:00": 117.2300033569336,
      "2024-08-26T15:30:00+00:00": 116.83999633789062,
      "2024-08-26T16:30:00+00:00": 116.55999755859375,
      "2024-08-26T17:30:00+00:00": 116.45999908447266,
      "2024-08-26T18:30:00+00:00": 116.38500213623047,
      "2024-08-26T19:30:00+00:00": 116.37000274658203
    },
    "sentiment": 0.8328474760055542
  },
  {
    "title": "With 78% ownership, Merck & Co., Inc. (NYSE:MRK) boasts of strong institutional backing",
    "published": 1724504411,
    "day_prices": {},
    "sentiment": 0.8393798470497131
  },
  {
    "title": "Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock",
    "published": 1724418017,
    "day_prices": {
      "2024-08-23T13:30:00+00:00": 116.80000305175781,
      "2024-08-23T14:30:00+00:00": 116.1500015258789,
      "2024-08-23T15:30:00+00:00": 116.31500244140625,
      "2024-08-23T16:30:00+00:00": 116.25,
      "2024-08-23T17:30:00+00:00": 116.18000030517578,
      "2024-08-23T18:30:00+00:00": 116.3563003540039,
      "2024-08-23T19:30:00+00:00": 116.38999938964844
    },
    "sentiment": 0.8854035139083862
  },
  {
    "title": "Health Canada Approves KEYTRUDA\u00ae for the treatment of adult patients with unresectable locally advanced or metastatic urothelial cancer (mUC) with no prior systemic therapy for mUC, in combination with enfortumab vedotin",
    "published": 1724324400,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 116.30000305175781,
      "2024-08-22T14:30:00+00:00": 115.80670166015625,
      "2024-08-22T15:30:00+00:00": 115.36000061035156,
      "2024-08-22T16:30:00+00:00": 116.43000030517578,
      "2024-08-22T17:30:00+00:00": 116.03500366210938,
      "2024-08-22T18:30:00+00:00": 116.30999755859375,
      "2024-08-22T19:30:00+00:00": 116.58999633789062
    },
    "sentiment": 0.563508927822113
  },
  {
    "title": "Merck receives Health Canada approval for Keytruda in the treatment of urothelial cancer",
    "published": 1724313540,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 116.30000305175781,
      "2024-08-22T14:30:00+00:00": 115.80670166015625,
      "2024-08-22T15:30:00+00:00": 115.36000061035156,
      "2024-08-22T16:30:00+00:00": 116.43000030517578,
      "2024-08-22T17:30:00+00:00": 116.03500366210938,
      "2024-08-22T18:30:00+00:00": 116.30999755859375,
      "2024-08-22T19:30:00+00:00": 116.58999633789062
    },
    "sentiment": 0.9310303926467896
  },
  {
    "title": "Jim Cramer Says He Has \u2018Tremendous Faith\u2019 Merck\u00a0(MRK) CEO",
    "published": 1724246949,
    "day_prices": {
      "2024-08-21T13:30:00+00:00": 114.77999877929688,
      "2024-08-21T14:30:00+00:00": 115.48999786376953,
      "2024-08-21T15:30:00+00:00": 115.30000305175781,
      "2024-08-21T16:30:00+00:00": 115.73999786376953,
      "2024-08-21T17:30:00+00:00": 115.76499938964844,
      "2024-08-21T18:30:00+00:00": 116.24500274658203,
      "2024-08-21T19:30:00+00:00": 116.29000091552734
    },
    "sentiment": 0.8193075060844421
  },
  {
    "title": "Merck Insiders Sell US$11m Of Stock, Possibly Signalling Caution",
    "published": 1724162408,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 114.76000213623047,
      "2024-08-20T14:30:00+00:00": 115.13999938964844,
      "2024-08-20T15:30:00+00:00": 114.83499908447266,
      "2024-08-20T16:30:00+00:00": 114.82499694824219,
      "2024-08-20T17:30:00+00:00": 114.9800033569336,
      "2024-08-20T18:30:00+00:00": 115.1500015258789,
      "2024-08-20T19:30:00+00:00": 115.05000305175781
    },
    "sentiment": 0.8627605438232422
  },
  {
    "title": "Buying Wonderful Businesses At Fair Prices - The Billionaire Way",
    "published": 1724052600,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 113.66000366210938,
      "2024-08-19T14:30:00+00:00": 113.7699966430664,
      "2024-08-19T15:30:00+00:00": 114.13999938964844,
      "2024-08-19T16:30:00+00:00": 114.0999984741211,
      "2024-08-19T17:30:00+00:00": 114.30500030517578,
      "2024-08-19T18:30:00+00:00": 113.91999816894531,
      "2024-08-19T19:30:00+00:00": 114.33000183105469
    },
    "sentiment": 0.8628953695297241
  },
  {
    "title": "Merck & Co., Inc. (MRK): The Best Defensive Stock Now According to Hedge Funds?",
    "published": 1723922490,
    "day_prices": {},
    "sentiment": 0.8157021403312683
  },
  {
    "title": "Merck & Co., Inc. (MRK): Hedge Funds Are Bullish on This Diabetes Stock Now",
    "published": 1723856060,
    "day_prices": {},
    "sentiment": 0.4526633024215698
  },
  {
    "title": "Merck : ESG Report",
    "published": 1723799959,
    "day_prices": {
      "2024-08-16T13:30:00+00:00": 113.61000061035156,
      "2024-08-16T14:30:00+00:00": 113.03009796142578,
      "2024-08-16T15:30:00+00:00": 113.31490325927734,
      "2024-08-16T16:30:00+00:00": 112.77999877929688,
      "2024-08-16T17:30:00+00:00": 112.83000183105469,
      "2024-08-16T18:30:00+00:00": 113.2300033569336,
      "2024-08-16T19:30:00+00:00": 113.18000030517578
    },
    "sentiment": 0.9383981823921204
  },
  {
    "title": "Unusual Put Option Trade in Merck (MRK)  Worth $3,060.00K",
    "published": 1723747165,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 114.16000366210938,
      "2024-08-15T14:30:00+00:00": 113.33000183105469,
      "2024-08-15T15:30:00+00:00": 113.1500015258789,
      "2024-08-15T16:30:00+00:00": 113.01499938964844,
      "2024-08-15T17:30:00+00:00": 112.58999633789062,
      "2024-08-15T18:30:00+00:00": 113.01000213623047,
      "2024-08-15T19:30:00+00:00": 113.05000305175781
    },
    "sentiment": 0.9386993646621704
  },
  {
    "title": "Medicare negotiates lower prices for 10 high-cost drugs",
    "published": 1723739688,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 114.16000366210938,
      "2024-08-15T14:30:00+00:00": 113.33000183105469,
      "2024-08-15T15:30:00+00:00": 113.1500015258789,
      "2024-08-15T16:30:00+00:00": 113.01499938964844,
      "2024-08-15T17:30:00+00:00": 112.58999633789062,
      "2024-08-15T18:30:00+00:00": 113.01000213623047,
      "2024-08-15T19:30:00+00:00": 113.05000305175781
    },
    "sentiment": 0.635405421257019
  },
  {
    "title": "Healthcare Stocks Rise despite Medicare Price Cuts for Their Drugs",
    "published": 1723718880,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 114.16000366210938,
      "2024-08-15T14:30:00+00:00": 113.33000183105469,
      "2024-08-15T15:30:00+00:00": 113.1500015258789,
      "2024-08-15T16:30:00+00:00": 113.01499938964844,
      "2024-08-15T17:30:00+00:00": 112.58999633789062,
      "2024-08-15T18:30:00+00:00": 113.01000213623047,
      "2024-08-15T19:30:00+00:00": 113.05000305175781
    },
    "sentiment": 0.9216431379318237
  },
  {
    "title": "3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct",
    "published": 1723630500,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 113.66000366210938,
      "2024-08-14T14:30:00+00:00": 112.0999984741211,
      "2024-08-14T15:30:00+00:00": 112.58999633789062,
      "2024-08-14T16:30:00+00:00": 113.20999908447266,
      "2024-08-14T17:30:00+00:00": 113.12000274658203,
      "2024-08-14T18:30:00+00:00": 113.181396484375,
      "2024-08-14T19:30:00+00:00": 113.45999908447266
    },
    "sentiment": 0.8525962233543396
  },
  {
    "title": "Video: Dow Movers: MRK, HD",
    "published": 1723627860,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 113.66000366210938,
      "2024-08-14T14:30:00+00:00": 112.0999984741211,
      "2024-08-14T15:30:00+00:00": 112.58999633789062,
      "2024-08-14T16:30:00+00:00": 113.20999908447266,
      "2024-08-14T17:30:00+00:00": 113.12000274658203,
      "2024-08-14T18:30:00+00:00": 113.181396484375,
      "2024-08-14T19:30:00+00:00": 113.45999908447266
    },
    "sentiment": 0.9464535713195801
  },
  {
    "title": "Assured Guaranty Ltd Faces Significant Reduction by Kahn Brothers in Q2 2024",
    "published": 1723613280,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 113.66000366210938,
      "2024-08-14T14:30:00+00:00": 112.0999984741211,
      "2024-08-14T15:30:00+00:00": 112.58999633789062,
      "2024-08-14T16:30:00+00:00": 113.20999908447266,
      "2024-08-14T17:30:00+00:00": 113.12000274658203,
      "2024-08-14T18:30:00+00:00": 113.181396484375,
      "2024-08-14T19:30:00+00:00": 113.45999908447266
    },
    "sentiment": 0.9664090275764465
  },
  {
    "title": "Genprex stock slides 14% following Reqorsa study updates",
    "published": 1723599120,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 113.66000366210938,
      "2024-08-14T14:30:00+00:00": 112.0999984741211,
      "2024-08-14T15:30:00+00:00": 112.58999633789062,
      "2024-08-14T16:30:00+00:00": 113.20999908447266,
      "2024-08-14T17:30:00+00:00": 113.12000274658203,
      "2024-08-14T18:30:00+00:00": 113.181396484375,
      "2024-08-14T19:30:00+00:00": 113.45999908447266
    },
    "sentiment": 0.9531115293502808
  },
  {
    "title": "Jefferies Keeps Their Buy Rating on Merck & Company (MRK)",
    "published": 1723533420,
    "day_prices": {
      "2024-08-13T13:30:00+00:00": 113.56999969482422,
      "2024-08-13T14:30:00+00:00": 114.68499755859375,
      "2024-08-13T15:30:00+00:00": 114.06999969482422,
      "2024-08-13T16:30:00+00:00": 114.08000183105469,
      "2024-08-13T17:30:00+00:00": 113.9800033569336,
      "2024-08-13T18:30:00+00:00": 113.86000061035156,
      "2024-08-13T19:30:00+00:00": 114.18000030517578
    },
    "sentiment": 0.9188081622123718
  },
  {
    "title": "Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical",
    "published": 1723460429,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 114.70999908447266,
      "2024-08-12T14:30:00+00:00": 114.04000091552734,
      "2024-08-12T15:30:00+00:00": 113.44000244140625,
      "2024-08-12T16:30:00+00:00": 113.78500366210938,
      "2024-08-12T17:30:00+00:00": 114.12000274658203,
      "2024-08-12T18:30:00+00:00": 113.66000366210938,
      "2024-08-12T19:30:00+00:00": 113.44000244140625
    },
    "sentiment": 0.6545208692550659
  },
  {
    "title": "Big drugmakers focus on smaller deals for biotech companies, WSJ reports",
    "published": 1723439340,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 114.70999908447266,
      "2024-08-12T14:30:00+00:00": 114.04000091552734,
      "2024-08-12T15:30:00+00:00": 113.44000244140625,
      "2024-08-12T16:30:00+00:00": 113.78500366210938,
      "2024-08-12T17:30:00+00:00": 114.12000274658203,
      "2024-08-12T18:30:00+00:00": 113.66000366210938,
      "2024-08-12T19:30:00+00:00": 113.44000244140625
    },
    "sentiment": 0.8316949009895325
  },
  {
    "title": "Week In Review: Curon Out-Licenses T-Cell-Engager To Merck For $700 Million Upfront",
    "published": 1723380480,
    "day_prices": {},
    "sentiment": 0.9168774485588074
  },
  {
    "title": "MSD sets sights on bispecific antibody market with Curon acqusition",
    "published": 1723232019,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 113.77999877929688,
      "2024-08-09T14:30:00+00:00": 113.29000091552734,
      "2024-08-09T15:30:00+00:00": 113.43000030517578,
      "2024-08-09T16:30:00+00:00": 114.02999877929688,
      "2024-08-09T17:30:00+00:00": 114.62999725341797,
      "2024-08-09T18:30:00+00:00": 114.0999984741211,
      "2024-08-09T19:30:00+00:00": 113.95999908447266
    },
    "sentiment": 0.6455549597740173
  },
  {
    "title": "Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion",
    "published": 1723205340,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 113.77999877929688,
      "2024-08-09T14:30:00+00:00": 113.29000091552734,
      "2024-08-09T15:30:00+00:00": 113.43000030517578,
      "2024-08-09T16:30:00+00:00": 114.02999877929688,
      "2024-08-09T17:30:00+00:00": 114.62999725341797,
      "2024-08-09T18:30:00+00:00": 114.0999984741211,
      "2024-08-09T19:30:00+00:00": 113.95999908447266
    },
    "sentiment": 0.6885868310928345
  },
  {
    "title": "Kahn Brothers Reduces Stake in MBIA Inc.",
    "published": 1723201320,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 113.77999877929688,
      "2024-08-09T14:30:00+00:00": 113.29000091552734,
      "2024-08-09T15:30:00+00:00": 113.43000030517578,
      "2024-08-09T16:30:00+00:00": 114.02999877929688,
      "2024-08-09T17:30:00+00:00": 114.62999725341797,
      "2024-08-09T18:30:00+00:00": 114.0999984741211,
      "2024-08-09T19:30:00+00:00": 113.95999908447266
    },
    "sentiment": 0.7286778092384338
  },
  {
    "title": "Merck acquires experimental product from Curon",
    "published": 1723192100,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 113.77999877929688,
      "2024-08-09T14:30:00+00:00": 113.29000091552734,
      "2024-08-09T15:30:00+00:00": 113.43000030517578,
      "2024-08-09T16:30:00+00:00": 114.02999877929688,
      "2024-08-09T17:30:00+00:00": 114.62999725341797,
      "2024-08-09T18:30:00+00:00": 114.0999984741211,
      "2024-08-09T19:30:00+00:00": 113.95999908447266
    },
    "sentiment": 0.8503998517990112
  },
  {
    "title": "Merck to buy experimental B-cell depletion therapy for $700M in cash upfront",
    "published": 1723185120,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 113.77999877929688,
      "2024-08-09T14:30:00+00:00": 113.29000091552734,
      "2024-08-09T15:30:00+00:00": 113.43000030517578,
      "2024-08-09T16:30:00+00:00": 114.02999877929688,
      "2024-08-09T17:30:00+00:00": 114.62999725341797,
      "2024-08-09T18:30:00+00:00": 114.0999984741211,
      "2024-08-09T19:30:00+00:00": 113.95999908447266
    },
    "sentiment": 0.5226001143455505
  },
  {
    "title": "Murray underperforms against benchmark, emphasises caution in outlook",
    "published": 1723178820,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 113.77999877929688,
      "2024-08-09T14:30:00+00:00": 113.29000091552734,
      "2024-08-09T15:30:00+00:00": 113.43000030517578,
      "2024-08-09T16:30:00+00:00": 114.02999877929688,
      "2024-08-09T17:30:00+00:00": 114.62999725341797,
      "2024-08-09T18:30:00+00:00": 114.0999984741211,
      "2024-08-09T19:30:00+00:00": 113.95999908447266
    },
    "sentiment": 0.7625842094421387
  },
  {
    "title": "J.P. Morgan Reaffirms Their Buy Rating on Merck KGaA (0O14)",
    "published": 1723166820,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 113.77999877929688,
      "2024-08-09T14:30:00+00:00": 113.29000091552734,
      "2024-08-09T15:30:00+00:00": 113.43000030517578,
      "2024-08-09T16:30:00+00:00": 114.02999877929688,
      "2024-08-09T17:30:00+00:00": 114.62999725341797,
      "2024-08-09T18:30:00+00:00": 114.0999984741211,
      "2024-08-09T19:30:00+00:00": 113.95999908447266
    },
    "sentiment": 0.830288827419281
  },
  {
    "title": "Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1723122018,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 112.91999816894531,
      "2024-08-08T14:30:00+00:00": 113.30000305175781,
      "2024-08-08T15:30:00+00:00": 113.08000183105469,
      "2024-08-08T16:30:00+00:00": 113.29000091552734,
      "2024-08-08T17:30:00+00:00": 113.69499969482422,
      "2024-08-08T18:30:00+00:00": 113.80999755859375,
      "2024-08-08T19:30:00+00:00": 114.16000366210938
    },
    "sentiment": 0.9174595475196838
  },
  {
    "title": "Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects",
    "published": 1723114500,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 112.91999816894531,
      "2024-08-08T14:30:00+00:00": 113.30000305175781,
      "2024-08-08T15:30:00+00:00": 113.08000183105469,
      "2024-08-08T16:30:00+00:00": 113.29000091552734,
      "2024-08-08T17:30:00+00:00": 113.69499969482422,
      "2024-08-08T18:30:00+00:00": 113.80999755859375,
      "2024-08-08T19:30:00+00:00": 114.16000366210938
    },
    "sentiment": 0.9312265515327454
  },
  {
    "title": "Looking Into Merck & Co's Recent Short Interest",
    "published": 1723113120,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 112.91999816894531,
      "2024-08-08T14:30:00+00:00": 113.30000305175781,
      "2024-08-08T15:30:00+00:00": 113.08000183105469,
      "2024-08-08T16:30:00+00:00": 113.29000091552734,
      "2024-08-08T17:30:00+00:00": 113.69499969482422,
      "2024-08-08T18:30:00+00:00": 113.80999755859375,
      "2024-08-08T19:30:00+00:00": 114.16000366210938
    },
    "sentiment": 0.9345278739929199
  },
  {
    "title": "Marks Electrical Group Shareholders Approve Resolutions",
    "published": 1723112340,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 112.91999816894531,
      "2024-08-08T14:30:00+00:00": 113.30000305175781,
      "2024-08-08T15:30:00+00:00": 113.08000183105469,
      "2024-08-08T16:30:00+00:00": 113.29000091552734,
      "2024-08-08T17:30:00+00:00": 113.69499969482422,
      "2024-08-08T18:30:00+00:00": 113.80999755859375,
      "2024-08-08T19:30:00+00:00": 114.16000366210938
    },
    "sentiment": 0.7725685238838196
  },
  {
    "title": "Merck: Phase III trial in lung cancer fails",
    "published": 1723103189,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 112.91999816894531,
      "2024-08-08T14:30:00+00:00": 113.30000305175781,
      "2024-08-08T15:30:00+00:00": 113.08000183105469,
      "2024-08-08T16:30:00+00:00": 113.29000091552734,
      "2024-08-08T17:30:00+00:00": 113.69499969482422,
      "2024-08-08T18:30:00+00:00": 113.80999755859375,
      "2024-08-08T19:30:00+00:00": 114.16000366210938
    },
    "sentiment": 0.8125765323638916
  },
  {
    "title": "Merck to discontinue Phase 3 KeyVibe-008 trial based on recommendation of DMC",
    "published": 1723096200,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 112.91999816894531,
      "2024-08-08T14:30:00+00:00": 113.30000305175781,
      "2024-08-08T15:30:00+00:00": 113.08000183105469,
      "2024-08-08T16:30:00+00:00": 113.29000091552734,
      "2024-08-08T17:30:00+00:00": 113.69499969482422,
      "2024-08-08T18:30:00+00:00": 113.80999755859375,
      "2024-08-08T19:30:00+00:00": 114.16000366210938
    },
    "sentiment": 0.8513468503952026
  },
  {
    "title": "Merck price target lowered by $8 at Berenberg, here's why",
    "published": 1723087740,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 112.91999816894531,
      "2024-08-08T14:30:00+00:00": 113.30000305175781,
      "2024-08-08T15:30:00+00:00": 113.08000183105469,
      "2024-08-08T16:30:00+00:00": 113.29000091552734,
      "2024-08-08T17:30:00+00:00": 113.69499969482422,
      "2024-08-08T18:30:00+00:00": 113.80999755859375,
      "2024-08-08T19:30:00+00:00": 114.16000366210938
    },
    "sentiment": 0.7973347306251526
  },
  {
    "title": "Unusual Put Option Trade in Merck (MRK)  Worth $2,377.50K",
    "published": 1723049710,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 111.25,
      "2024-08-07T14:30:00+00:00": 111.4000015258789,
      "2024-08-07T15:30:00+00:00": 111.09500122070312,
      "2024-08-07T16:30:00+00:00": 111.22000122070312,
      "2024-08-07T17:30:00+00:00": 111.0999984741211,
      "2024-08-07T18:30:00+00:00": 111.41000366210938,
      "2024-08-07T19:30:00+00:00": 111.16999816894531
    },
    "sentiment": 0.9390107989311218
  },
  {
    "title": "Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070",
    "published": 1722941100,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 112.30000305175781,
      "2024-08-06T14:30:00+00:00": 112.66000366210938,
      "2024-08-06T15:30:00+00:00": 112.31909942626953,
      "2024-08-06T16:30:00+00:00": 111.98999786376953,
      "2024-08-06T17:30:00+00:00": 112.41000366210938,
      "2024-08-06T18:30:00+00:00": 112.4000015258789,
      "2024-08-06T19:30:00+00:00": 111.80000305175781
    },
    "sentiment": 0.8851131796836853
  },
  {
    "title": "Merck, Daiichi Sankyo expand cancer drug deal",
    "published": 1722926040,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 112.30000305175781,
      "2024-08-06T14:30:00+00:00": 112.66000366210938,
      "2024-08-06T15:30:00+00:00": 112.31909942626953,
      "2024-08-06T16:30:00+00:00": 111.98999786376953,
      "2024-08-06T17:30:00+00:00": 112.41000366210938,
      "2024-08-06T18:30:00+00:00": 112.4000015258789,
      "2024-08-06T19:30:00+00:00": 111.80000305175781
    },
    "sentiment": 0.8345943689346313
  },
  {
    "title": "Merck, Daiichi Sankyo enter commercialization agreement for MK-6070",
    "published": 1722923340,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 112.30000305175781,
      "2024-08-06T14:30:00+00:00": 112.66000366210938,
      "2024-08-06T15:30:00+00:00": 112.31909942626953,
      "2024-08-06T16:30:00+00:00": 111.98999786376953,
      "2024-08-06T17:30:00+00:00": 112.41000366210938,
      "2024-08-06T18:30:00+00:00": 112.4000015258789,
      "2024-08-06T19:30:00+00:00": 111.80000305175781
    },
    "sentiment": 0.8540918827056885
  },
  {
    "title": "Organon extends selloff after Q2 results",
    "published": 1722907800,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 112.30000305175781,
      "2024-08-06T14:30:00+00:00": 112.66000366210938,
      "2024-08-06T15:30:00+00:00": 112.31909942626953,
      "2024-08-06T16:30:00+00:00": 111.98999786376953,
      "2024-08-06T17:30:00+00:00": 112.41000366210938,
      "2024-08-06T18:30:00+00:00": 112.4000015258789,
      "2024-08-06T19:30:00+00:00": 111.80000305175781
    },
    "sentiment": 0.9131352305412292
  },
  {
    "title": "DZ BANK AG Sticks to Their Buy Rating for Merck KGaA (0O14)",
    "published": 1722849960,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 114.94999694824219,
      "2024-08-05T14:30:00+00:00": 112.73500061035156,
      "2024-08-05T15:30:00+00:00": 112.72000122070312,
      "2024-08-05T16:30:00+00:00": 113.29000091552734,
      "2024-08-05T17:30:00+00:00": 112.51329803466797,
      "2024-08-05T18:30:00+00:00": 112.62999725341797,
      "2024-08-05T19:30:00+00:00": 111.9800033569336
    },
    "sentiment": 0.7034595608711243
  },
  {
    "title": "Merck's Blockbuster Vaccine Gardasil Sales In China: Analyst Highlights Challenges and Opportunities",
    "published": 1722821400,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 114.94999694824219,
      "2024-08-05T14:30:00+00:00": 112.73500061035156,
      "2024-08-05T15:30:00+00:00": 112.72000122070312,
      "2024-08-05T16:30:00+00:00": 113.29000091552734,
      "2024-08-05T17:30:00+00:00": 112.51329803466797,
      "2024-08-05T18:30:00+00:00": 112.62999725341797,
      "2024-08-05T19:30:00+00:00": 111.9800033569336
    },
    "sentiment": 0.8105540871620178
  },
  {
    "title": "What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.",
    "published": 1722622934,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 115.16000366210938,
      "2024-08-02T14:30:00+00:00": 116.08999633789062,
      "2024-08-02T15:30:00+00:00": 114.87999725341797,
      "2024-08-02T16:30:00+00:00": 115.19200134277344,
      "2024-08-02T17:30:00+00:00": 115.25499725341797,
      "2024-08-02T18:30:00+00:00": 115.41000366210938,
      "2024-08-02T19:30:00+00:00": 115.3499984741211
    },
    "sentiment": 0.895336389541626
  },
  {
    "title": "Interesting MRK Put And Call Options For March 2025",
    "published": 1722591900,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 115.16000366210938,
      "2024-08-02T14:30:00+00:00": 116.08999633789062,
      "2024-08-02T15:30:00+00:00": 114.87999725341797,
      "2024-08-02T16:30:00+00:00": 115.19200134277344,
      "2024-08-02T17:30:00+00:00": 115.25499725341797,
      "2024-08-02T18:30:00+00:00": 115.41000366210938,
      "2024-08-02T19:30:00+00:00": 115.3499984741211
    },
    "sentiment": 0.9394443035125732
  },
  {
    "title": "Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut",
    "published": 1722586020,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 115.16000366210938,
      "2024-08-02T14:30:00+00:00": 116.08999633789062,
      "2024-08-02T15:30:00+00:00": 114.87999725341797,
      "2024-08-02T16:30:00+00:00": 115.19200134277344,
      "2024-08-02T17:30:00+00:00": 115.25499725341797,
      "2024-08-02T18:30:00+00:00": 115.41000366210938,
      "2024-08-02T19:30:00+00:00": 115.3499984741211
    },
    "sentiment": 0.8316537141799927
  }
]